StemCell Therapy

Supporting people on their journey to realizing wholeness

Welcome! At the UF Health Integrative Medicine Program we treat the whole person mind, body and spirit and are dedicated to helping you achieve optimal health and well-being in all aspects of life.

Formally launched in 2013, the UF Health Integrative Medicine Program began out of an interest from the UF Health Shands Arts in Medicine to extend the hospital-based yoga, massage and meditation services they offered to patient families, caregivers and the hospital staff directly to the patients. Recognizing that an integrative approach to healing best addresses the needs of the whole person mind, body and spirit they established a partnership with the UF Department of Medicine to develop an integrative medicine program. With local philanthropic support, commitment from the College of Medicine and the UF Health Shands Hospital, they recruited Irene M. Estores, MD to develop and grow this program. Dr. Estores serves as the medical director for program, continuing her many years of experience and interest in integrative medicine.

UF Health Integrative Medicine utilizes safe and effective therapies from both conventional medicine and traditional healing practices, like medical acupuncture and meditation, to provide patients with an evidence-informed, non-pharmacological health plan to help achieve their goals.

Continue reading here:
About Us | Integrative Medicine | UF Health, University of ...

Overview

The Division of Molecular Genetics and the Leibel Laboratory focus on the genetics of obesity and non-insulin dependent diabetes (diabetes mellitus type 2). The laboratory has mapped, cloned, and identified mutations in the obese, diabetes, and fatty genes in humans, rats, and mice, and focuses on defining the physiological basis by which signaling networks regulate body size and composition. The laboratory is also the Molecular Biology Core laboratory of the New York Obesity Research Center and the Columbia Diabetes Research Center.

Members of the lab are experts in the use of naturally occurring and transgenic rodent models to identify candidate molecules, and in vetting these candidates in large numbers of human subjects using high throughput methods (SNP detection, copy number analysis, and high throughput sequencing).

The division also co-administers research activities for the Naomi Berrie Diabetes Center, making this a division that operates across many scientific and administrative areas of the university.

Programs and centers include:

The Division of Molecular Genetics provides opportunities for graduate students to receive training and mentorships leading to a doctorate degree. Interested students who have been accepted into the Columbia University Graduate School of Arts and Sciences can rotate through our laboratories before deciding whether to consider their research projects in our labs under the mentorship of our faculty.

Frontiers in Diabetes Research provides fellowship awards to post docs and awards to research scholars based on a competitive application process. Award recipients receive awards for one year, with the opportunity to continued research support for a second year. This program includes an annual topic-specific research symposium.

Russell Berrie Obesity Research Initiative (Leibel and Zuker) provides awards to senior investigators for research projects in the area of neuroscience of ingestive behavior and body weight regulation. Additional awards are made for and feasibility studies. There is a competitive application process each year. Awards may be made for one year, with the opportunity for a second year of funding.

The Molecular Genetics Fellowship is a non-ACGME accredited program that provides opportunities for postdoctoral training in the genetic basis for monogenic or complex medical and physiological phenotypes using both human and animal models. Areas of special interest are obesity, types 1 and 2 diabetes, MODY, breast cancer, pulmonary hypertension, congenital heart disease, cardiomyopathies, inherited arrhythmias, congenital diaphragmatic hernias, oral clefts, and spinal muscular atrophy.

The Division of Molecular Genetics was created in 1997 with the recruitment of Rudolph Leibel, MD as division chief.

Link:
Molecular Genetics | Department of Pediatrics

Why do some cancer cells get away? Heather Lee, NewcastleNewborn babies offer clues for healing hearts Enzo Porrello, MelbourneWinners of the National Stem Cell Foundation of Australias 2018 Metcalf Prizes announcedDr Heather Lee is analysing individual cancer cells to understand how some survive therapy. Her research ultimately aims to prevent relapse and lift survival rates for leukaemia. Associate Professor Enzo Porrello is exploring newborn heart development to develop heart attack drugs and engineer artificial pumps from patient stem cells.Heather Lee of the University of Newcastle and Enzo Porrello of the University of Melbourne have both received $50,000 Metcalf Prizes from the National Stem Cell Foundation of Australia in recognition of their early-career leadership in stem cell research.Heather invented a way to study the genetics of individual cells more closely that will help her find out why some cancer cells are treatable, and others go rogue. With her new technique, she can see the chemical flags that tell the cell how to interpret its genetic code. At the same time, she can watch how those instructions areor arentcarried out.Heather and other scientists use the technique to study what makes rogue cancer cells different at a genetic level.Heather is now studying cells from patients with acute myeloid leukaemia to see how just a few cells can resist treatment and go on to cause a fatal relapse. She hopes this will lead to new, more effective drug treatments for this devastating disease.Dr Heather Lee is a Cancer Institute NSW Fellow at Hunter Medical Research Institute and the University of Newcastle.Read Heather's full profile.For a few short days after birth, the heart can regenerate damaged tissue. Enzo wants to understand why this ability turns off, so that he and colleagues can switch it back on to heal broken hearts. Understanding regeneration could lead to new treatments for different types of heart disease, the worlds biggest killer, from birth defects to heart attacks late in life.I recently showed that the hearts of newborn mice can regenerate after a heart attack, Enzo says. But this self-healing ability rapidly diminishes in the days after birth.Enzo thinks there is a similar capacity in humans. He is using stem cells to recreate the development of the heart in the lab to study the processes and the genes involved in turning self-healing on and off.He wants to develop drugs that can stimulate heart muscle cells to rebuild after a heart attack.He is also part of a new consortium that aims to engineer new working heart tissue to treat children with heart disease, made from their own stem cells.Associate Professor Enzo Porrello is Group Leader of Cardiac Regeneration at the Murdoch Childrens Research Institute (MCRI) and a Senior Research Fellow at the University of Melbourne.Read Enzo's full profile.We hope that supporting Heather Lees work will help her share a valuable new technique for cancer researchers, and that Enzo Porrellos work will help us tackle Australias biggest killer, says Dr Graeme Blackman, AO, the chairman of the Foundation.Once again, weve been stunned by the quality of the applications. Heather and Enzo stood out from a very competitive field of young research leaders.The awards are named for the late Professor Donald Metcalf AC. Over his 50-year career, Don helped transform cancer treatment and transplantation medicine, and paved the way for potential stem cell therapy in the treatment of many other conditions.Professor Richard Larkins AO will formally present the 2018 Metcalf Prizes for Stem Cell Research at a special event in Melbourne on Friday 30 November 2018.Click here for full media kit and photographs.About the National Stem Cell Foundation of AustraliaThe NSCFA is an ATO-registered, tax-deductible health promotion charity dedicated to promoting the study and responsible use of stem cells to reduce the burden of disease.The Foundations activities include:supporting research that pursues cures for as-yet-untreatable diseasesbuilding a community of people with a shared interest in stem cell scienceproviding the Australian public with objective, reliable information on both the potential and risks of stem cell medicine.The Foundation is led by an expert volunteer Board, with a diversity of scientific, medical and governance experience. The Chairman is Dr Graeme Blackman, AO, FTSE, FAICD.The Board consults with leading stem cell scientists before committing funds to research and education initiatives.

Original post:
National Stem Cell Foundation of Australia

Genetic engineering is also known as genetic modification. It is the process by which a new type of DNA is manually added to an organism, or the manipulation or modification of the genome of an organism by use of biotechnology. The main goal of genetic engineering is to add a new gene into the target organism, to enable it to mimic the trait encoded by the inserted gene. Genetic engineering involves finding an organism that naturally contains the desired trait and extracting the DNA from which the desired gene is located and copying it. This process is known as gene cloning (Council for Responsible Genetics). The extracted gene may be slightly modified before insertion into the target organism. The new gene is known as transgene. The transgene is inserted into the cells of the recipient organism, a process known as transformation. Genetic engineering is different from traditional breeding because genetic engineering involves manually moving genes from one organism to another, while in traditional breeding genes move through crossing or mating. This essay discusses human genetic engineering, and the legal and ethical issues surrounding human genetic engineering (Isasi, Knoppers, & Nguyen, 2006).

Association of Reproductive Health Professionals defines Human genetic engineering (HEG) or Human Genetic Modification (HGM) as a process through which medical professionals and scientists alter the DNA or genetic makeup of a living human cell. HGE is used to fix genetic complications and genetic genes that cause diseases. In order to alter the genes, a new gene is inserted into an organism resembling a virus, which penetrates a cell and inserts a new gene into the targeted genome (Council for Responsible Genetics). HGM utilizes two applications to alter genes: germline and somatic. Germline engineering targets the genes in embryos, sperm, and eggs, in early developmental stages. The human genetic modifications affect every cell created in the developing embryo. Germline modifications are passed from generation to generation. Somatic engineering targets certain genes in specific tissues or organs without any interference with the genes in sperms or eggs. The aim for somatic engineering is to cure or treat an existing condition, and does not alter genetic makeup (Haga & Willard, 2006).Compared to somatic,germline engineering is more controversialsince it affects the future of reproduction, because germline modifications are passed from generation to generation (Isasi et al., 2006).

Cloning is considered a third method of HGE (Annas, Andrews, & Isasi, 2002). The US Department of Energy genomics divides cloning into three: therapeutic cloning, reproductive cloning, and DNA cloning or recombinant DNA technology (Bledrzycki, 2005). Therapeutic cloning or embryo cloning involves producing human embryos to be utilized in scientific research. Reproductive cloning is the generation of an organism possessing similar nuclear DNA as another organism. DNA cloning involves transferring a DNA part from an organism to a genetic element with self-replicating abilities to enable the DNA to undergo self-replication in a foreign host cell (Annas et al., 2002).

HGE has various advantages. It has the capacity to eradicate the development of disease processes. The gene mutations can arrest diseases like cystic fibrosis, cardiac diseases, and Alzheimers disease. Genetic Engineering could lead to detection of people that are genetically prone to certain hereditary diseases, and prepare them to deal with the expected outcomes (Bledrzycki, 2005). More informed knowledge and understanding of genetics aids in the discovery of better pharmacological or pharmaceutical products. Genetic Engineering can increase the life span of the human population. Scientists argue that by use of genetic modification, the average range of human life span could be increased to anywhere from 100 and 150 years because the modifications can lead to a deceleration in aging process (Bledrzycki, 2005).

One major setback of using HGE, is that the after-effects or consequences are not yet known. Scientists in the effort to cure one disease can inadvertently facilitate another disease to flourish (Haga & Willard, 2006). Genetic Engineering has borderline issues on many moral practices, particularly involving religion, which questions whether human beings have the right to manipulate the laws or course of nature. If all the defective genes are altered with better functional genes, genetic diversity will fade away due to the fact that all humans will have the same genome or traits (Annas et al., 2002). As a result, the human population may be susceptible to unknown forms of diseases or even viruses, and this may lead to the extinction of the human population on earth (Simmons, 2008).

The laws regulating and governing human genetic engineering differ from one country to another. In 2013, the United States debated whether they should ban prenatal engineering. The Australian government prohibits germline therapy through the Prohibition of Human Cloning Act (Rosario, Knooppers, & Nguyen, 2006). Countries that have developed laws prohibiting human gene engineering include Canada, Germany, and the United States. Countries like France, China, and Japan have set up guidelines that monitor gene therapy in clinical trials. The rest of the world has no laws for or against gene therapy. For example, in India, the Indian Council of Medical Research (ICMR) considers gene therapy a matter of ethical considerations, as it involves humans as subjects in the research process. ICMR also supports gene therapy as it believes that it will alleviate the human suffering (Rosario et al., 2006).

The human genome project is a scientific project that was funded by the United States government. The project lasted thirteen years. During the project, several legal issues were raised concerning human genetics. In criminal law, lawyers argued that genetic engineering causes antisocial conduct and disorders which affects society at large. Lawyers also stated that the Free will of the participants was violated, since most of the participants were either tricked or coerced into the project (Rosario et al., 2006).

Lawyers pointed out the issue of privacy and confidentiality, which is a basic right for patients, based on the Hippocratic Oath. In cases of genetic characteristics disorder, the question as to whether the patient is treated individually or as the entire family emerges as they all suffer from the same condition of genetic characteristics. Another issue is whether the family is allowed access to the data about the patients genes since the family shares genetic features with the patient, which is relevant to the whole family (Bledrzycki, 2005)

Another legal issue concerning human genetic engineering is intellectual property rights. Will the law permit patentability of the human genome for use in therapeutics? Lawyers argued that the human genome is a common heritage of all humanity, and it is possessed by human species as a whole. Others argued that it is possessed by God and not corporate organizations involved in scientific research (Haga & Willard, 2006).

The issue of human rights is also considered. Human genetic engineering provides an avenue to reconcile the human genome with development of genetic technology. This infringes on human dignity and human rights (Annas et al., 2002). The UNESCO declaration, in article 6, states that, No one shall be subjected to discrimination based on genetic characteristics that is intended to infringe or has the effect of infringing human rights, fundamental freedoms and human dignity. Since HGE involves altering of a persons genes, a legal issue arises when parents manipulate a childs genes without the childs consent. This is a violation of the rights and dignity of the unborn child. Scientists discovered that genes that trigger genetic diseases constitute a great part of the inherited causes of human suffering (Haga & Willard, 2006). Human genetic allows identification of people who carry such genes. This knowledge would lead to abortions, and allow future elimination of people who are carriers of heritable diseases. The lawyers question if this is a desirable step. The process of medical elimination has no set boundaries. Elimination of people living with the genetic conditions is a form of discrimination and disrespect to life as there is no lesser life than the other (Haga & Willard, 2006).

There has been a public policy debate over the years over the use of Genetic Engineering. The debate has been steered by the spiritual leaders, who question the use of genetic engineering in cloning. Genetic cloning is used as a new form of procreation, which differs with the biblical knowledge of how procreation should take place. The clergy consider cloning as a deviation from the spiritual laws, hence the opposition. No human should alter the process of procreation (Anna et al., 2002).

The technology of genetic engineering is expensive. Therefore, only the privileged members of the society will have the ability to afford it and have designer babies, who possess greater physical attractiveness and intelligence (Haga & Willard, 2006). In the end, this will lead to new forms of inequality and discrimination due to the creation of aristocracy. It could also lead to the emergence of marginalized individuals who will be unable to have a family, insurance, job, or healthcare. Insurance companies might use genetic information of these individuals for risk assessment process which may cause declining of their application for insurance as they are associated with increased health risks. The available genetic information could also be used by employers in screening out workers with specific undesired genes (Bledrzycki, 2005). Bioethicists have also called for a ban on some of the species altering technologies recommended and enforced by any international tribunal. This is because of the concern that such genetic engineering could be used to make a slave race (Bledrzycki, 2005).

Cloning is mainly applied in reproductive failure or in couples that are both sterile or couples where both partners are carriers of an autosomal recessive genetic disorder. Cloning is used to provide a genetically linked offspring to the couple. Scientists argue that the right to clone children who are genetically related should only be denied if there is great harm (Haga & Willard, 2006). There has equally been a debate on the differing child parentage in genetic engineering. Some people believe that the father and the mother who contributed most of the childs genome should be the true parents of the child, while others believe that the donor should also have a part to play in the childs life. This leads to emergence of the legal question on who is to get the full custody of the child (Bledrzycki, 2005).

Another legal issue arising from Genetic Engineering is whether there are adequate resources for the genetic technologies. Some people believe that there are more important areas of medical practice that need to be invested in, rather than genetic modification. There are people who argue that the alternative options of having children, for example, adoption and egg donation, are more rational and cheap compared to gene cloning. The funds used for HGE can be better put to use in other medical issues (Haga & Willard, 2006).

Another legal question that arises concerning human genetic engineering is whether the law should intervene in cases where human genome is altered. There is rising concern about what Genetic modification will do to society. Some think that there will be an overdependence on genetic engineering, which may allow more dangerous biological technologies to be legalized in the future (Haga & Willard, 2006).

Annas, G.A., Andrews, L.B. & Isasi R.M. (2002) Protecting the Endangered Human: Toward an International Treaty Prohibiting Cloning and Inheritable Alterations. American Journal of Law and Medicine. 28(2&3): 154

Bledrzycki, B.A. (2005). Genetic Discrimination It Could Happen To You.ONS News,20 (13): 8-9

Council for Responsible Genetics. Human Genetic Engineering Current Science and Ethical Implications. CRG. Web.

Haga, S.B. & Willard, H.F. (2006). Defining the spectrum of genome policy. Perspectives. 7: 967-970

Isasi, R.M., Knoppers, B.M. & Nguyen, M.T. (2006). National Regulatory Frameworks Regarding Human Genetic Modification Technologies (Somatic and Germline Modification). A Report for the Genetics and Public Policy Center.

Kaufman, D., Curnutte, M., & McGuire, A.M. (2014). Clinical Integration of Next Generation Sequencing:A Policy Analysis. Journal of law, medicine & ethics

Rosario M., Knooppers, B.M. & Nguyen T.M. (2006). Policies Regarding Human Genetic Modification Technologies: A Report for the Genetics and Public Policy Center.National Regulatory Frameworks Regarding Human Genetic Modification Technologies (Somatic And Germline Modification).

Simmons,D.(2008)Genetic inequality: Human genetic engineering.Nature Education1(1):173

5.00 avg. rating (99% score) - 1 vote

Read the original:
Legal and Ethical Issues in Genetic Engineering Bad Essay ...

Stem Cell Therapy has been around for quite some time, but due to high cost it was primarily used for recovery in athletes and the financial elite. However, with the progression of science and knowledge, stem cell therapy has become much more widely used and financially attainable.

Tampa Rejuvenation is the first in Tampa Bay to utilize the benefits of stem cell therapy for the purpose of anti-aging and sexual performance. We realize as our patients age, their bodies no longer have the regenerative properties to attain the desired results from using their growth factors alone as with our PRP, or Plasma Rich Platelet, therapy. Although many patients will still yield improvement with the PRP alone, the magnitude of cytokines and growth factors in your blood as you age will deplete with age. By implementing stem cell therapy, the number of growth factors are exponential allowing our bodies to regenerate on a magnitude that is otherwise unattainable with some results lasting for 3-5 years.

Stem Cell Therapy can be used to restore vitality to the skin, encourage the growth of hair, and even restore sexual performance and pleasure.

Follow this link:
Stem Cell Therapy for Anti-Aging and Sexual Performance ...

Degenerative Disc Disease (DDD), Herniated Discs & Sciatica Causing Lumbar Back Pain

What is degenerative disc disease and what are the symptoms?

Spinal disc degeneration and disc herniations are two of the most common causes of back pain, affecting in particular the lumbar spine (low back). Spinal discs are soft, compressible structures that separate the vertebrae of the spine. The discs act as shock absorbers, allowing the spine to flex, bend, and twist.

Sciatica is the name for the horrible leg pain that is caused when a bulging lumbar disc irritates a lumbar nerve root. The discomfort can be a combination of burning pain and numbness that responds poorly to pain medication.

There is a normal amount of expected wear and tear of our spinal discs as we age. On the other hand, arthritis, injury, and extreme wear and tear of sports can accelerate the degeneration. On a cellular level, there is continual loss of healthy cells inside the disc that is responsible for the discs structure. Over time, normal cells are damaged and hydration is lost, leading to tears in the internal structure of the discs.

When discs degenerate, mobility is affected and function is limited, resulting in symptoms that include stiffness, weakness, and ultimately, unrelenting pain.

What is spinal facet disease and what are the symptoms?

Spinal facet disease is one of the most common causes of neck and back pain and can cause pain at any level of the spine. The spinal facets joints are located on both sides of the back of each spinal segment. They connect each spinal level and are responsible for stabilizing the vertebral bodies and counterbalancing the intervertebral discs. The facets can be injured during acute trauma often seen in flexion extension injuries such as a whiplash event or sports accident. The surfaces of the facet joints are covered by articular cartilage and are also prone to chronic degenerative arthritis much like the larger joints such as knees and hips.

Pain that is caused by facet dysfunction is typically isolated to the back of the lumbar spine, thoracic region and neck. The discomfort can be isolated to one side or may affect both sides of the spine at once. The pain may radiate into the muscles but does not extend into the extremities like sciatic pain that is caused from a disc herniation. Typically the pain is worsened with extension and or rotation of the neck or back. Diagnosis of facet pain begins with a physical exam and imaging studies, but often requires diagnostic injection with local anesthetic and or steroid to confirm the diagnosis.

When the facet joints are injured mobility is affected and function is limited, resulting in symptoms that can mimic disc disease such as stiffness, weakness, and ultimately, unrelenting pain.

Original post:
Stem Cell Therapy for Back Pain - ThriveMD Vail & Denver, CO

What are stem cells?

Stem cells are the basic building blocks of human tissue and have the ability to repair, rebuild, and rejuvenate tissues in the body. When a disease or injury strikes, stem cells respond to specific signals and set about to facilitate the healing process by stimulating your own body to repair itself.

Stem cells that come from perinatal tissue(healthy post-natal C-sections) have distinct functional properties including immunomodulation and anti-inflammation which support the repair and regeneration of damaged tissue associated with disease and injury.

There are four known types of stem cells which include:

We provide allogeneic regenerative cytokines and mesenchymal stem cells from health post-natal C-sections.

We tap into our bodys stem cell reserve daily to repair and replace damaged or diseased tissue. When the bodys reserve is limited and as it becomes depleted, the regenerative power of our body decreases and we succumb to disease and injury.

Three sources of stem cells from a patients body are used clinically which include adipose tissue (fat), bone marrow and umbilical cord matrix(Whartons Jelly).

We provide stem cell therapy for a wide variety of musculoskeletal conditions for which traditional treatment offers less than optimal options. Some conditions include Osteoarthritis, Bursitis, Plantar Fasciitis and Degenerative Disc Disease

Since each condition and patient are unique, there is no guarantee of what results will be achieved or how quickly they may be observed. According to patient feedback, many patients report results in one to three months, however, it may take as long as six to nine months. Individuals interested in stem cell therapy are urged to consult with their physician before choosing investigational allogeneic umbilical cord derived regenerative medicine allografts as a treatment option.

In order to determine if you are a good candidate for a regenerative medicine treatment, you will need to complete a medical history form which will be provided by our patient advocate team. Once you complete and submit your medical history form, our medical team will review your records and determine if you are a qualified candidate for a regenerative medicine therapy.

The side effects of intra-articular injection of a regenerative medicine allograft are minimal and may include but are not limited to: infection, minor bleeding at the treatment sites and localized pain. However, these side effects typically last no longer than 24 hours.

We provide regenerative medicine allografts from healthy post-natal C-section births that provide regenerative factors and mesenchymal stem cells. Embryonic stem cells are typically associated with ethical concerns. We do not offer embryonic stem cells.

Our regenerative medicine allografts are regulated as human cell and tissue transplants, similar to skin and bone. As structural human cell and tissue products regulated under FDA CFR 1271 Part 361, our allografts do not require FDA approval, rather we are strictly regulated to prevent the spread of communicable diseases and to maintain the structural integrity of the allografts as theyre harvested from umbilical cords and transferred for musculoskeletal cushioning, protection and supplementation. These regenerative allografts are FDA regulated rather than FDA approved. The FDA is a regulatory oversight body and doesnt exercise legal authority. If an FDA regulated tissue transplant or therapy is noted as non-compliant and not corrected according to FDA guidelines, the FDA may refer a significant public health risk to the Department of Justice or a state attorney general.

Stem cell treatment is not covered by health insurance at this time.

Although stem cells are found throughout our bodies, mesenchymal stem cells can only be harvested for native (non-cultured) use from adipose, bone marrow and umbilical cord matrix. The term amniotic stem cells is an oxymoron in that amniotic fluid and matrix products dont contain stem cells. They do however contain unique cytokines and other growth factors.

See the article here:
Stem Cell Therapy - Top Rated Local Stem Cell Treatment In ...

Course Director: Richard Hayden, M.D.

The symposium will feature presentations on the latest advancements in regenerative medicine and surgery. Networking opportunities are available and the symposium is open to specialists and non-specialists alike who are interested in regenerative medicine therapies and techniques.

Registration Fee

POSTERS

Researchers are invited to submit abstracts for posters. First place posters in each category will be awarded complimentary registration for the 2019 meeting.

Special priority will be given to posters that focus on:

The deadline for abstract submissionis September 30, 2018. Those with accepted abstracts will be notifiedby October 5, 2018. If your abstract is selected, you must register to attend.

TO SUBMIT AN ABSTRACT

1. You must create a User Profile

2. Fill out the Abstract Submission

SPONSORSHIP OPPORTUNITIES

Applications for sponsorships and exhibitors are now closed. Thank you for your interest.

Exhibitor AgreementWestin Shipment NotificationWestin WKR Exhibit Order Form

Link:
Mayo Clinic Symposium on Regenerative Medicine & Surgery ...

Sessions and Tracks

Theme:

About Conference:

The 11th International conference onPredictive Preventive and PersonalizedMedicine & Molecular Diagnostics will be held on October 25-26, 2019 at Vancouver, Canada.whichcomprises 18Sessions/Tracksto outline the theme of the conference organized by Conference series LLC LTD. The main aim of the conference is to highlight the achievements and innovations in the various fields of Personalized Medicine across the globe.

Tracks: 1 Paths of Biomarkers

In medication, a biomarker and sub-atomic markers are the quantifiable pointer of the seriousness or vicinity of some infection state. All the more by and large a biomarker is anything that can be utilized as a marker of a specific ailment state or some other physiological condition of a living being Drug-Diagnostic Co-Development. In the present period of stratified solution and biomarker-driven treatments, the centre has moved from forecasts taking into account the conventional anatomic arranging frameworks to direct the decision of treatment for an individual patient to a coordinated methodology utilizing the hereditary cosmetics of the tumour and the genotype of the patient. Genomics and other innovations have to a great extent added to the recognizable proof and the improvement of biomarkers such as Stratification biomarkers in customized pharmaceutical.

Track 2: Clinical Case Reports: Genetics

Customized solution depends on interspecies contrasts. It is proverbial that little contrasts in hereditary make-up can bring about emotional contrasts because of medications or ailment and societal effect of customized pharmaceutical. To express this in more broad terms in any given complex framework, little changes in beginning conditions can bring about drastically diverse results. In spite of human variability and interspecies variety in different species, nonhuman species are still the essential model for finding out information for personalized solution wellbeing change in Human.

Track 3: Life Style Medicine

Life Medicine (LM) is the utilization of way of life mediations in the treatment and administration of infection. LM is turning into the favoured methodology for the counteractive action as well as the treatment of most perpetual sicknesses, including Type-2 Diabetes, Coronary Heart Disease, Hypertension, Obesity, Insulin Resistance Syndrome, Osteoporosis, malignancy prevention. Likewise incorporate Aerobic and Resistance practices for patients with diabetes, Sleep and infection counteractive action, intrinsic inspiration and wellbeing conduct adherence.

Track 4: Preventive Medicine

Preventive Medicine is honed by all doctors to keep their patients sound. It is additionally an exceptional medicinal claim to fame perceived by the American Board of Medical Specialties (ABMS). Preventive Medicine concentrates on the wellbeing of people, groups, and characterized populaces. It is likewise utilized for the treatment for stoutness, visual impairment. The Epidemiology Division applies research strategies to comprehend the examples and reasons for wellbeing and ailment in the populace and to make an interpretation of this learning into projects intended to avert malady. The division has a long history of inclusion in NIH-supported multi-site, longitudinal partner studies, and its personnel manage numerous specialist started, NIH-supported exploration ventures and trials.

Track 5: Personalized Medicine & its Innovation

Personalized Medicine is a developing routine of medication that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, determination, and treatment of ailment. Information of a patient's hereditary profile can offer specialists some assistance with selecting the best possible prescription or treatment and manage it utilizing the correct measurement or regimen. Utilized for the treatment as Personalized growth solution, Diabetes-related sickness: hazard appraisal and administration, Personalized pharmaceutical: New procedures and monetary ramifications, Implications of customized prescription in treatment of HIV, Applications of customized drug in uncommon illnesses, Translational Medicine.

Track 6: Advances in Molecular Diagnostics

Personalized Medicine is a developing routine of medication that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, determination, and treatment of ailment. Information of a patient's hereditary profile can offer specialists some assistance with selecting the best possible prescription or treatment and manage it utilizing the correct measurement or regimen. Utilized for the treatment as Personalized growth solution, Diabetes-related sickness: hazard appraisal and administration, Personalized pharmaceutical: New procedures and monetary ramifications, Implications of customized prescription in treatment of HIV, Applications of customized drug in uncommon illnesses, Translational Medicine.

Track 7: Market Strategies & Challenges In Personalised Medicine

P4 Medicine is an arrangement to profoundly enhance the nature of human life by means of biotechnology. P4 Medicine is a term authored by scholar Leroy Hood, and is another way to say "Predictive, Preventive, Personalized Medicine, and Molecular Medicine." The reason of P4 Medicine is that, throughout the following 20 years, restorative practice will be altered by biotechnology, to deal with a man's wellbeing, rather than deal with a patient's infection. Inner solution or general medication (in Commonwealth countries) is the medicinal claim to fame managing the avoidance, determination, and treatment of grown-up maladies. Crisis solution is a medicinal claim to fame including watch over grown-up and paediatric patients with intense sicknesses or wounds that require quick therapeutic consideration.

Track 9: Novelty in Personalised Medicine

Personalized Medicine is a developing routine of prescription that uses an individual's hereditary profile to guide choices made with respect to the counteractive action, analysis, and treatment of malady. Learning of a patient's hereditary profile can offer specialists some assistance with selecting the correct prescription or treatment and control it utilizing the best possible measurements or regimen. Utilized for the treatment as Personalized malignancy pharmaceutical, Diabetes-related sickness: hazard evaluation and administration, Personalized drug: New procedures and monetary ramifications, Implications of customized medication in treatment of HIV, Applications of customized prescription in uncommon infections, Translational Medicine.

Track 10: Genomics & Personalized Medicine

Genomics is a control in hereditary qualities that applies Recombinant DNA, DNA sequencing techniques, and bioinformatics to grouping, amass, and break down the capacity and structure of genomes. Propels in genomics have set off an insurgency in disclosure based examination to see even the most complex organic frameworks, for example, the mind. The field incorporates endeavours to decide the whole DNA grouping and human genome variation of life forms and fine-scale hereditary mapping. The field additionally incorporates investigations of intragenomic marvels, for example, heterosis, epistasis, pleiotropy and different associations in the middle of loci and all within the genome and met genomics.

Track 11: Genetics of Ebola Outbreak

Arrangement investigation of Ebola infection Genome is the second through the 6th qualities of the Ebola infection (EBO) genome demonstrates that it is sorted out also to rhabdoviruses and paramyxoviruses and is for all intents and purposes the same as Marburg infection (MBG). Researchers utilized genomic sequencing advancements to recognize the starting point and track transmission of the Ebola infection in the ebb and flow flare-up in Africa.

Track 12: Approaches To Stem Cells

Personalized Medicine can be utilized to find out around a man's hereditary cosmetics and to disentangle the science of their tumour. Utilizing this data, specialists want to recognize anticipation, screening, and treatment techniques that might be more successful and cause less symptoms than would be normal with standard medicines. By performing more hereditary tests and examination, specialists might alter treatment to every patient's needs. Making a customized malignancy screening and treatment arrangement incorporates: Determining the odds that a man will create growth and selecting screening techniques to bring down the danger, Matching patients with medications that will probably be compelling and cause less reactions, Predicting the danger of repeat (return of Cancer)

Track 13: Nanotechnology: Future of Personalised Medicine

Nanotechnology ("nanotech") is the control of matter on a nuclear, atomic, and supramolecular scale. The soonest, across the board portrayal of nanotechnology alluded to the specific mechanical objective of accurately controlling particles and atoms for creation of macro scale items, likewise now alluded to as sub-atomic nanotechnology. Uses of pharmaceutical Nano tools, Cell based treatment Molecular systems are the strategies and instrument in Nano innovation and biotechnology.

Track 14: Personalized Drug Therapy

The personalizeddrug is a field of medication that involves foreseeing the likelihood of malady and establishing preventive measures keeping in mind the end goal to either keep the ailment by and large or altogether abatement its effect upon the patient, (for example, by avoiding mortality or constraining dreariness). Methods and measures incorporate New-born screening,Diagnostic testing, Medical bioinformatics, Prenatal testing, Carrier testing, Preconception testing. Infant screening is a general wellbeing program intended to screen babies not long after conception for a rundown of conditions that are treatable, however not clinically clear in the infant period. Pre-birth testing: Prenatal testing is utilized to search for sicknesses and conditions in a hatchling or developing life before it is conceived. This kind of testing is offered for couples who have an expanded danger of having a child with a hereditary or chromosomal issue.

Track 15: Personalized Oncology

The era of personalized oncology medicine has the potential to fulfil the promise of delivering the right dose for the right indication to the right patient at the right time. Imagine your oncologist knowing before he makes a treatment decision how well your cancer may respond to a particular therapy. Tools that enable a more informed treatment decision do exist and may help individualize your cancer care. It is very important for oncologists to keep updated of the latest advancements in oncology as changes in management of cancer are quite common. All fit patients whose cancer progresses and no standard of care treatment options are available should be enrolled in a clinical trial. Personalized medicine is used to learn about a persons genetic makeup and how their tumor grows. Using this data, doctors hope to find prevention, screening, and treatment strategies that may be more effective. They also want to find ones that cause fewer side effects than the standard treatments. By performing more genetic tests, doctors may customize treatment to each patients needs.

Track 16: Immunology Infectious Disease

Clinical immunology is the study of diseases caused by disorders of the immune system. It also involves diseases of other systems, where immune reactions play a part in the pathology and clinical features. Many components of the immune system are actually cellular in nature and not associated with any specific organ but rather are embedded or circulating in various tissues located throughout the body. Immunotherapy is a new class of cancer treatment that works to harness the innate powers of the immune system to fight cancer. Because of the immune system's unique properties, these therapies may hold greater potential than current treatment approaches to fight cancer more powerfully, to offer longer-term protection against the disease, to come with fewer side effects, and to benefit more patients with more cancer types. Scientists believe that for most people, Alzheimer's disease results from a combination of genetic, lifestyle and environmental factors that affect the brain over time. In Parkinsons disease, cells that produce dopamine start to die. Dopamine is a chemical that helps you move normally. There is no known direct cause of Parkinsons. One theory is that it may be hereditary. Other theories say exposure to pesticides and living in rural communities may cause it.

Track 17: Cardiology and Vascular Medicine

The objective of the Cardiac Research is to quicken interpretation of promising new crucial examination revelations for the treatment of heart disappointment and arrhythmias through very much composed clinical trials that exhibit viability and security. Vascular Medicine envelops a wide range of different disease states. As the field of vascular Medicine develops, the extent of illnesses being dealt with changes. Cardiovascular renovating alludes to the adjustments in size, shape, structure and physiology of the heart after damage to the myocardium. The harm is normally because of intense myocardial dead tissue. To portray the expansion in lipoprotein interpretation by hypothyroidism, adipocytes were readied from control and hypothyroid rats. While LPL combination was higher in hypothyroid adipocytes, with no adjustment in mRNA levels, there was no expansion in hormone-touchy lipase (HSL) blend.

Read more here:
Medicine conferences 2019: Personalized | Predictive ...

About he conference

It is our most prominent joy to welcome you to the official site of Cancer Research 2019, that goes for uniting the teachers, scientists, clinicians, instructors, program engineers to give a worldwide gathering to the spread of unique research results, new thoughts and viable advancement encounters which focus on both hypothesis and practices in our Therapeutic gatherings. The gathering will be on August 22-23, 2019 in Tokyo, Japan. The subject of the gathering is near, "Rising and Imaginative methodologies for the progression of disease treatment. The disease is a harmful development or a tumor coming about because of an uncontrolled division of cells. Malignancy is the second most regular reason for death in the European Association. Malignancy of the bosom and lung tumors is the main growth composes in European guys and females. The weight of new growth cases in 2010 was assessed to associate with 3 million, in European areas to 53% of this heap. The weight of tumor is expanding worldwide regardless of advances in growth finding and treatment. Notwithstanding, the overall growth insights delineate that 1 million grown-ups on the planet were determined to have the disease and 1.7million passings happened in 2012 in Europe and 7.4 million internationally.

Cancer is the most essential reason for death and horribleness in Europe after cardiovascular diseases. Cancer is, as a rule, avoidable, and early recognition builds the possibility of fix generously. Mostly every now and again happening type of the Cancer ailment in the EU are colorectal, bosom, prostate, and lung cancers. In men, lung cancer is the most continuous reason for cancer demise, while in ladies, it is bosom cancer. In the two people, colorectal cancer is the second most basic reason for cancer demise. Albeit noteworthy advances are being made in the battle against the infection, cancer remains a key general wellbeing concern and a colossal weight on European Cancer Societies.

Whats New?

The thoughts which you are working or looking on may require some extraordinary procedures for the finish. In this way, this meeting gives a stage to share thoughts as individuals over the globe will assemble at a similar place from various locales, nations, colleges. Individuals with the diverse thought are additionally welcome to demonstrate their work or exhibit the work and even they can impart the plan to the general population of various thoughts, can team up the work, and can examine with the gatherings of people.

Notwithstanding creating our very own oncology gatherings, cancer gatherings, cancer gatherings, oncology meetings we participate with national oncology affiliations and establishments, cancer alliances and other neighbourhood gatherings to guarantee the most astounding scholarly gauges in their projects and to animate proceeding with medicinal oncology instruction and preparing.

About Tokyo City

Tokyo was some time ago named Edo when Shgun Tokugawa Ieyasu made the city as his home office in 1603. It turned into the capital after Emperor Meiji moved his seat to the city from Kyoto in 1868; around then Edo was renamed Tokyo. Tokyo Metropolis was shaped in 1943 from the merger of the previous Tokyo Prefecture. The city of Tokyo has 39 million occupants, half a greater number of individuals than some other urban region, with a $2.5 trillion economy bigger than that of some other city; in the event that it was a nation, Tokyo would be the eighth biggest economy on the planet. Tokyo is frequently alluded to as a city, however, is formally referred to and administered as a "metropolitan prefecture", which contrasts from and consolidates components of a city and a prefecture. The Tokyo Metropolitan Government directs the 23 Special Wards of Tokyo (each administered as an individual city), which cover the region that was the city of Tokyo before it consolidated and turned into the metropolitan prefecture in 1943, the 30 districts in the western piece of the prefecture, and the two remote island chains. The number of inhabitants in the exceptional wards is more than 9 million individuals, with the aggregate populace of the prefecture surpassing 13 million. Tokyo is positioned first in the Global Economic Power Index and third in the Global Cities Index

Review of Tracks

This gathering is anticipated gynecologic oncologists, therapeutic oncologists, radiation oncologists, understudy, occupants in these zones, and look into researchers, specialists, doctor colleagues, and different clinicians engaged with this meeting to share your logical thoughts in this logical condition.

Track 1: Cancer Research

Cancer explore is an examination into harm to perceive causes and make frameworks for neutralizing activity, investigation, treatment, and fix. Tumor investigates ranges from the investigation of malady transmission, sub-nuclear bioscience to the execution of clinical primers to evaluate and consider the use of the distinctive development drugs. These applications fuse medicinal technique, radiation treatment, chemotherapy, hormone treatment, and immunotherapy, and united treatment modalities, for instance, chemo-radiotherapy. Starting in the mid-1990s, the emphasis in clinical harm ask about moved towards medications got from biotechnology investigate, for instance, tumor immunotherapy and quality treatment.

Track 2: Cancer Genetics

Cancer is a hereditary infection activated by an expansion of DNA changes and epigenetic modifications that prompts uncontrolled cell multiplication and neoplasm arrangement. The change happens much of the time in the collection of human still it can ready to remedy a large portion of the transformations. Thus, it won't be conceivable to cause cancer with one change. For the most part, it takes various transformations in a lifetime of a human to cause cancer. This is the reason senior individuals have cancer, as they have had various possibilities for change. Oncogenomic manages the portrayal of cancer-related qualities. Tumor silencer qualities or oncogenes are the ones that deal with the phone cycle process, so they are known as the defensive cells. These hereditary changes heighten the danger of cancer. The nearness of changed qualities in germ cells can be acquired to the offsprings. Cancer Pharmacology manages the activity of the medication on cancer patients. Cancer science Meetings investigates the new thoughts and procedures of cancer treatment.

Track 3: Cancer Epigenetics

Cancer epigenetics is the investigation of epigenetic alterations to the DNA of cancer cells that don't include an adjustment in the nucleotide arrangement. Epigenetic changes might be similar as imperative, or significantly more critical, than hereditary transformations in a cell's change to cancer. In cancers, loss of articulation of qualities happens around 10 times all the more oftentimes by translation quieting (caused by epigenetic promoter hypermethylation of CpG islands) than by transformations. As Vogelstein et al. call attention to, in colorectal cancer, there are for the most part around 3 to 6 driver changes and 33 to 66 drifter or traveller transformations. In any case, in colon tumors contrasted with neighbouring ordinary seeming colonic mucosa, there are around 600 to 800 intensely methylated CpG islands in promoters of qualities in the tumors while these CpG islands are not methylated in the contiguous mucosa.

Track 4: Cancer Science

Cancer Science is a broad field that arrangements with cancer research and treatment. Cancer, once considered as a lethal infection, however now with an improvement in cancer inquire about the circumstance has changed. It is considered a gigantic accomplishment as there are distinctive treatments accessible currently to treat and analyse cancer. The focused on cancer treatment is one of the best treatments in regarding cancer as it includes, the treating of the cancer cells by focusing on and restraining the particular particles that are a requirement for the tumor movement. This blocking should be possible by sub-atomic medication. The Cancer Case Reports demonstrates the undeveloped cell treatment as a functioning treatment of cancer. Cancer biomarkers help in discovering tumor cells and treating them. Tumor Immunology assumes an imperative job in a finding of new methodologies for cancer therapeutics. Cancer Conferences communicates its push to relinquish cancer from the world.

Track 5: Cancer diagnostics

The worldwide cancer diagnostics showcase extension was esteemed at USD 124.0 billion of every 2016 and is relied upon to develop at a CAGR of 7.2% over the figure time frame. Constrained diagnostics progressions have achieved a diminishing of 30% in bosom cancer. Henceforward, the imaging part in the overall Oncological diagnostics market will proceed with its everlasting inside a sensible time span. The general Cancer Diagnostics Market can be distributed into blood cancer, kidney sickness, bosom cancer, prostate development, pancreatic development, ovarian tumor, lung cancer, and liver cancer. The overall cancer diagnostics advertise is for the most part evaluated by enhancing the enthusiasm for lung cancer and bosom cancer investigation. The lung cancer area is driving the market, as it is the most prevalent sort of threat.

Track 6: Cancer Therapies & prevention

It is a method for diagnosing the ailment and utilizing an extensive variety of medications and systems. Homegrown medication utilizes plants, or blends of plant extricate, to treat sickness and advance well-being. It means to re-establish your body's capacity to ensure, control, and recuperate itself. It is an entire body approach, so takes a gander at your physical, mental, and enthusiastic prosperity. It is occasionally called phytomedicine, phototherapy, or natural drug. Naturopathic authorities (NDs) assume that cancer rises up out of an unevenness that causes a basic breakdown inside the body. Homoeopathy relies upon the theory of treating like with like. Therefore, to treat an ailment a homoeopathic advisor (homoeopath) utilizes minor dosages of a substance that in extensive measurements would really cause the side effects of the sickness.

Track 7: Cancer Stem Cells

Cancer stem cells (CSC's) are subpopulations of cancer cells that can self-recharge, create different cells in the tumor mass, and manage tumorigenesis. Cancer specialists guess that tumors emerge from cancer stem cells that begin because of mutational hits on ordinary stem cells, by the change of confined forebear cells or even the separated cells that get a self-restoring limit. Cancer stem cells drive tumor movement, repeat after chemotherapy medicines, and have as of late moved toward becoming focuses for cancer stem cell treatments. Since both ordinary stem cells and cancer cells have the capacity to self-recharge, numerous pathways that are traditionally connected with cancer are likewise associated with the control of typical stem cell advancement including Notch, Wnt, Shh and established pluripotency translation factor pathways.

Track 8: Biomarkers

The expression "biomarker", a portmanteau of "natural marker", alludes to a general subcategory of medicinal signs that is, target signs of the restorative state saw from outside the patient which can be estimated precisely and reproducibly. Therapeutic signs remain rather than restorative side effects, which are constrained to those signs of wellbeing or ailment seen by patients themselves. There are a few more exact meanings of biomarkers in the writing, and they, luckily, cover extensively. In 1998, the National Institutes of Health Biomarkers Definitions Working Group characterized a biomarker as a trademark that is unbiased estimated and assessed as a marker of ordinary organic procedures, pathogenic procedures, or pharmacologic reactions to a remedial mediation.

Track 9: Biopsy

Cancer biopsy is the expulsion of tissue with a specific end goal to inspect it for the sickness. The tissue tests can be taken from any piece of the body. Biopsies are performed in a few diverse ways. A few biopsies include evacuating a little measure of tissue with a needle while others include precisely expelling a whole protuberance, or knob, that is suspicious. Regularly, the tissue is evacuated by putting a needle through the skin (percutaneous) to the region of irregularity. Biopsies can be securely performed with imaging direction, for example, ultrasound, x-beam, registered tomography (CT), or attractive reverberation imaging (MRI). These kinds of imaging are utilized to decide precisely where to put the needle and play out the biopsy.

Track 10: Chemotherapy

Chemotherapy (Chemo) is a sort of treatment that incorporates a drug or mix of pharmaceuticals to treat cancer. The objective of chemo is to stop or moderate the development of cancer cells. Chemo is viewed as a fundamental treatment. This implies it might influence your whole body. Chemo drugs assault quickly developing cancer cells; however, they can likewise influence sound cells that develop quickly. Chemotherapy is the use of any solution to treat any sickness. Regardless, to large number individuals, the word chemotherapy infers drugs used for malady treatment. It's as often as possible shortened to "chemo." Surgery and radiation treatment evacuate, murder, or mischief infection cells in a particular district, yet chemo can work all through the whole body. This infers chemo can wreck threat cells that have spread (metastasized) to parts of the body a long way from the primary (basic) tumor.

Track 11: Cancer screening

Dissimilar to analytic endeavours provoked by manifestations and restorative signs, disease screening includes endeavours to identify malignancy after it has framed, yet before any detectable indications show up. This may include physical examination, blood or pee tests, or medicinal imaging. Disease screening isn't accessible for some sorts of tumors. Notwithstanding when tests are accessible, they may not be suggested for everybody. All inclusive screening or mass screening includes screening everybody. Specific screening distinguishes individuals who are at higher hazard, for example, individuals with a family history. A few variables are considered to decide if the advantages of screening exceed the dangers and the expenses of screening.

Track 12: Cancer Immunotherapy

Cancer immunotherapy (now and again called immuno-oncology) is the counterfeit incitement of the invulnerable framework to treat cancer. It is a use of the key research of cancer immunology and a developing subspecialty of oncology. It abuses the way that cancer cells regularly have atoms on their surface that can be identified by the invulnerable framework, known as tumor antigens; they are frequently proteins or different macromolecules (e.g. sugars). Immunotherapies can be arranged as a dynamic, uninvolved or half breed (dynamic and aloof). Dynamic immunotherapy guides the invulnerable framework to assault tumor cells by focusing on tumor antigens. Inactive immunotherapies upgrade existing enemy of tumor reactions and incorporate the utilization of monoclonal antibodies, lymphocytes, and cytokines.

Track 13: Cancer Operomics

The recognizable proof of coding successions in various species, incorporating human sooner rather than later, has introduced the post-genome period. In this time, advancements are getting to be accessible that permit the profiling of tissues and cell populaces at the genomic, transcriptomic and proteomic levels. The atomic investigation of tissues at all three levels has been alluded to as operomics. This audit covers some essential innovations for operomics and their application to some lymphoid issue. It is suggested that nobody sort of investigation is completely instructive and that data that can be gotten from the diverse compartments enveloped in operomics is complimentary. Prospects for bringing such profiling advances into the clinical research facility will rely upon their strength, their ease of use and the clinical significance of the additional data they give, which can't be caught through different advances being used in the clinical lab.

Track 14: Carcinogenesis

Lately new improvements in cytogenetic, immunophenotyping and molecular biology have significantly propelled our comprehension of leukaemia. Tragically, customary morphologic assessment of intense myeloblastic leukaemia utilizing the French-American-British characterization corresponds ineffectively with a large portion of this new data and does not anticipate the reaction to treatment. In this audit, we focus on uses of molecular biologic procedures to the determination of leukaemia and examine utilization of this innovation to identify the insignificant lingering illness. We at that point present an amended grouping for intense myeloblastic leukaemia as indicated by whether myelodysplasia-like highlights are available or lacking. Cases may then be additionally characterized utilizing French-American-British morphology and different parameters. This grouping seems to relate better with new biologic information and with remedial reaction.

Track 15: Cancer nursing care

Cancer Nursing is a field including practice envelops the jobs of the direct parental figure, instructor, advisor, manager, and scientist. Cancer nursing reaches out to all mind conveyance settings where customers encountering or in danger of creating cancer get human services, training, and advising for cancer counteractive action, screening and identification. It additionally includes fitting screenings and other safeguard hones, manifestation administration, care to hold however much typical working as could reasonably be expected, and strong measures upon the finish of life.

Track 16: Cancer awareness

Expanded cancer mindfulness enhances survival. Social and Economic Impact additionally hurt the nature of cancer care. Individuals who are fiscally not solid don't get great treatment. Cancer side effect mindfulness and cancer survival are related. Cancer Awareness Program is directed by the administration and numerous associations to acquire the mindfulness the general population to diminish the cancer levels and towards all oncology programs. Crusades should centre on enhancing mindfulness about cancer indications, particularly in financially denied territories.

Track 17: Experimental Therapeutics

Experimental therapeutics is the advancement of treatment systems that all the more viable and particularly treat human illness with less danger. Research in experimental therapeutics coordinates different teaches to comprehend the malady from the sub-atomic to organismal levels and afterwards endeavours to apply this information to distinguish and approve targets, find and create intercessions or medications to control these objectives, and at last drive preclinical and clinical examinations to achieve the objective of the customized drug.

Track 18: Organ-specific cancer

The piece of genomics that recognizes cancer-united qualities was related to oncogenomics. It focuses on epigenetic, genomic, and record modifications in cancer. The headway from ordinary tissue to threatening cancer was thought to happen over a time of 5 20 years. Acquired hereditary variables, substantial hereditary adjustments, and transformations change were resolved, and it results in uncontrolled cell development and prompts passing. Cancer-causing qualities have been classified as proto-oncogenes (e.g., the qualities for MYC, ERBB2, and EGFR) and tumor silencer qualities, for example, the qualities that encode TP53, CDKN2A, and RB. The achievement of the Human Genome Project streamlined the field of oncogenomics and improved the abilities of scientists to the revelation of oncogenes.

Track 19: Radiation therapy

As a general term, radiation implies influxes of vitality, for example, light or warmth. The type of radiation utilized in cancer treatment is a high-vitality composes known as ionizing radiation. Precisely how radiation functions as a treatment for cancer are mind-boggling and yet being examined, however on a straightforward level it separates the DNA of cancer cells in a way that disturbs their development and division and can even execute them. Radiation treatment will here and there be utilized without anyone else, and now and again will be utilized close by other cancer medications, for example, chemotherapy, if a cancer master chooses that this will upgrade the impact of the treatment. Roughly 60 for each penny of individuals being dealt with for cancer in the United States will get radiation treatment.

Track 20: Cancer alternative medicine

Cancer treatments incorporate Complementary and Alternative Medicine, which are for the most part non-standard practices. As of late, CAM treatments are picking up significance in overseeing unfavourable manifestations of Cancer. In the event that a non-standard treatment is utilized together with the customary drug, it's considered as "Reciprocal treatment." If a non-standard treatment is utilized instead of ordinary pharmaceutical, it's considered as "Elective treatment." CAM comprises medications that depend on prescientific ideas of human physiology and pathology. A great many people who utilize non-standard methodologies utilize them alongside customary medications. CAM treatments incorporate a wide assortment of botanicals and healthful items, for example, dietary enhancements, natural enhancements, and vitamins.

Track 21: Cancer survivors

We can call dietary as eating routine treatment. As it is a strategy for giving the best possible sustenance to the patient endorsed by the specialists. Treatment of the patient includes sustenance for a superior state of the wellbeing. Because of cancer patients, slim down is essential to make due for an extended stretch. Picking correct sort of the sustenance when cancer treatment is vital. As the cancer patient should require every one of the vitamins and in addition nourishment. The point when the body isn't furnished with the best possible sustenance then the patient will experience the ill effects of the ailing health. In a few conditions, the tumors in our body make synthetics that divert the method for supplements use. Cancer medications make the patient harder to devour the sustenance and vitamin. The reactions caused by the treatment of cancer.

Track 22: Malignancy aggravation

At the point when threatening tumors are discovered after intense injury, medico-legal angles regularly enter the photo and impressive examination might be important to decide the circumstances and end results relationship. Ewing discovered it for the most part concurred, and it appears to be still to be the accord, that a solitary injury infrequently creates a harmful tumor in already ordinary tissue. To implicate solitary damage, the accompanying criteria would need to be met: There must be nonattendance of past injury, and the injury is referred to must be adequate to create a change of the tissue structure.

Track 23: Personalized medicine

Customized drug or accuracy solution is a therapeutic model that isolates individuals into various gatheringswith medicinal choices, practices, intercessions, as well as items being custom-made to the individual patient in view of their anticipated reaction or danger of malady. The terms personalized medicine, accuracy medicine, stratified medicine and P4 medicine are utilized reciprocally to portray this idea, however, a few creators and associations utilize these articulations independently to demonstrate specific subtleties. Various qualities all in all impact the probability of creating numerous normal and complex infections. The customized drug can likewise be utilized to foresee a man's hazard for a specific infection, in view of one or even a few qualities.

Worldwide Cancer Diagnostics advertise is relied upon to develop from $8.54 billion out of 2016 to reach $22.41 billion by 2023 with a CAGR of 8 %. Expanding frequency of cancer illnesses, developing mindfulness about human services, and later mechanical progressions in symptomatic gadgets are a portion of the elements moving the market development. Moreover, ideal government repayment approaches, expanding interests in innovative work exercises are some different elements boosting the market development amid the estimated time frame.

Then again, high expenses of analytic gadgets, strict controls for new item endorsements are the variables restricting the market development. Just 10% of patients determined to have a harmful neoplasm get by for over five years. Colorectal cancer (of the colon and rectum), the most widely recognized threatening tumor in the event that we amass people together, presents a normal survival rate of 50-55% five years after analysis, implying that a large portion of the patients survives this type of cancer. Prostate cancer, today the most widely recognized tumor in men, has an inexorably great prognosis, with a worldwide survival rate of 76%, which is higher in youthful grown-ups. Ovarian cancer displays an exceptionally shifted prognosis relying upon age: while 70% of the gathering somewhere in the range of 15 and 44 years survives this type of cancer, this is the situation for just 19% of those more than 74 years of age. Consistently omics arranges cancer gatherings in Europe.

Cancer Survivors Market analysis

For the result of legislative FA, an expanded Cox relapse display was connected to the entire companion, with age at growth conclusion as the timedependent variable, yielding risk proportions (HRs) with 95% certainty interims (CIs). This strategy was decided to completely exploit the forthcoming idea of the information and to represent the adjustments in risk rates over the span of followup. The followup for this investigation began at age 18 years (guardians are obliged by law to maintain their youngsters until that age) and finished at the date of the principal event an individual got FA, blue pencilling at the date of death, resettlement, or December 31, 2007, whichever happened first.

Cancer survivors were additionally classified into significant cancer gatherings (leukaemia, lymphoma, focal sensory system [CNS] tumors, testicular tumors, dangerous melanoma, bone and delicate tissue sarcomas, cancers of the female genital tract [cervix/uterus/ovarian], and "other"). Survivors likewise were arranged into CCS (those aged < 15 years at cancer conclusion) and AYAs (ages 1524 years at cancer determination). Examinations was being balanced for a year of birth and for parental instruction(the most elevated training accomplished by the two guardians)separated into 3 classificationsbring down training (<11 years), middle of the road instruction (1114 years), and tertiary training (>14 years) to represent contrasts in family financial status as a conceivable confounder.27 Marital status was incorporated as an arbiter in early investigations yet was excluded in the last model, in light of the fact that the appraisals delivered were comparative, and modifying for this variable could have presented colliderstratification inclination.

Major cancer associations across the globe

Top universities related to cancer

Pharmaceutical Companies Related to Cancer:

More:
Upcoming Cancer Conferences 2019 | Oncology Conferences ...

Bone marrow is a semi-solid tissue which may be found within the spongy or cancellous portions of bones.[2] In birds and mammals, bone marrow is the primary site of new blood cell production or hematopoiesis.[3] It is composed of hematopoietic cells, marrow adipose tissue, and supportive stromal cells. In adult humans, bone marrow is primarily located in the ribs, vertebrae, sternum, and bones of the pelvis.[4] On average, bone marrow constitutes 4% of the total body mass of humans; in an adult having 65 kilograms of mass (143 lb), bone marrow typically accounts for approximately 2.6 kilograms (5.7lb).[5]

Human marrow produces approximately 500 billion blood cells per day, which join the systemic circulation via permeable vasculature sinusoids within the medullary cavity.[6] All types of hematopoietic cells, including both myeloid and lymphoid lineages, are created in bone marrow; however, lymphoid cells must migrate to other lymphoid organs (e.g. thymus) in order to complete maturation.

Bone marrow transplants can be conducted to treat severe diseases of the bone marrow, including certain forms of cancer such as leukemia. Additionally, bone marrow stem cells have been successfully transformed into functional neural cells,[7] and can also potentially be used to treat illnesses such as inflammatory bowel disease.[8]

The composition of marrow is dynamic, as the mixture of cellular and non-cellular components (connective tissue) shifts with age and in response to systemic factors. In humans, marrow is colloquially characterized as "red" or "yellow" marrow (Latin: medulla ossium rubra, Latin: medulla ossium flava, respectively) depending on the prevalence of hematopoetic cells vs fat cells. While the precise mechanisms underlying marrow regulation are not understood,[6] compositional changes occur according to stereotypical patterns.[9] For example, a newborn baby's bones exclusively contain hematopoietically active "red" marrow, and there is a progressive conversion towards "yellow" marrow with age. In adults, red marrow is found mainly in the central skeleton, such as the pelvis, sternum, cranium, ribs, vertebrae and scapulae, and variably found in the proximal epiphyseal ends of long bones such as the femur and humerus. In circumstances of chronic hypoxia, the body can convert yellow marrow back to red marrow to increase blood cell production.[10]

At the cellular level, the main functional component of bone marrow includes the progenitor cells which are destined to mature into blood and lymphoid cells. Marrow contains hematopoietic stem cells which give rise to the three classes of blood cells that are found in circulation: white blood cells (leukocytes), red blood cells (erythrocytes), and platelets (thrombocytes).[11]

The stroma of the bone marrow includes all tissue not directly involved in the marrow's primary function of hematopoiesis.[6] Stromal cells may be indirectly involved in hematopoiesis, providing a microenvironment that influences the function and differentiation of hematopoeietic cells. For instance, they generate colony stimulating factors, which have a significant effect on hematopoiesis. Cell types that constitute the bone marrow stroma include:

The bone marrow stroma contains mesenchymal stem cells (MSCs),[11] also known as marrow stromal cells. These are multipotent stem cells that can differentiate into a variety of cell types. MSCs have been shown to differentiate, in vitro or in vivo, into osteoblasts, chondrocytes, myocytes, marrow adipocytes and beta-pancreatic islets cells.

The blood vessels of the bone marrow constitute a barrier, inhibiting immature blood cells from leaving the marrow. Only mature blood cells contain the membrane proteins, such as aquaporin and glycophorin, that are required to attach to and pass the blood vessel endothelium.[13] Hematopoietic stem cells may also cross the bone marrow barrier, and may thus be harvested from blood.

The red bone marrow is a key element of the lymphatic system, being one of the primary lymphoid organs that generate lymphocytes from immature hematopoietic progenitor cells.[14] The bone marrow and thymus constitute the primary lymphoid tissues involved in the production and early selection of lymphocytes. Furthermore, bone marrow performs a valve-like function to prevent the backflow of lymphatic fluid in the lymphatic system.

Biological compartmentalization is evident within the bone marrow, in that certain cell types tend to aggregate in specific areas. For instance, erythrocytes, macrophages, and their precursors tend to gather around blood vessels, while granulocytes gather at the borders of the bone marrow.[11]

Animal bone marrow has been used in cuisine worldwide for millennia, such as the famed Milanese Ossobuco.[citation needed]

The normal bone marrow architecture can be damaged or displaced by aplastic anemia, malignancies such as multiple myeloma, or infections such as tuberculosis, leading to a decrease in the production of blood cells and blood platelets. The bone marrow can also be affected by various forms of leukemia, which attacks its hematologic progenitor cells.[15] Furthermore, exposure to radiation or chemotherapy will kill many of the rapidly dividing cells of the bone marrow, and will therefore result in a depressed immune system. Many of the symptoms of radiation poisoning are due to damage sustained by the bone marrow cells.

To diagnose diseases involving the bone marrow, a bone marrow aspiration is sometimes performed. This typically involves using a hollow needle to acquire a sample of red bone marrow from the crest of the ilium under general or local anesthesia.[16]

Bone marrow derived stem cells have a wide array of application in regenerative medicine.[17]

Medical imaging may provide a limited amount of information regarding bone marrow. Plain film x-rays pass through soft tissues such as marrow and do not provide visualization, although any changes in the structure of the associated bone may be detected.[18] CT imaging has somewhat better capacity for assessing the marrow cavity of bones, although with low sensitivity and specificity. For example, normal fatty "yellow" marrow in adult long bones is of low density (-30 to -100 Hounsfield units), between subcutaneous fat and soft tissue. Tissue with increased cellular composition, such as normal "red" marrow or cancer cells within the medullary cavity will measure variably higher in density.[19]

MRI is more sensitive and specific for assessing bone bone composition. MRI enables assessment of the average molecular composition of soft tissues, and thus provides information regarding the relative fat content of marrow. In adult humans, "yellow" fatty marrow is the dominant tissue in bones, particularly in the (peripheral) appendicular skeleton. Because fat molecules have a high T1-relaxivity, T1-weighted imaging sequences show "yellow" fatty marrow as bright (hyperintense). Furthermore, normal fatty marrow loses signal on fat-saturation sequences, in a similar pattern to subcutaneous fat.

When "yellow" fatty marrow becomes replaced by tissue with more cellular composition, this change is apparent as decreased brightness on T1-weighted sequences. Both normal "red" marrow and pathologic marrow lesions (such as cancer) are darker than "yellow" marrow on T1-weight sequences, although can often be distinguished by comparison with the MR signal intensity of adjacent soft tissues. Normal "red" marrow is typically equivalent or brighter than skeletal muscle or intervertebral disc on T1-weighted sequences.[20][9]

Fatty marrow change, the inverse of red marrow hyperplasia, can occur with normal aging,[21] though it can also be seen with certain treatments such as radiation therapy. Diffuse marrow T1 hypointensity without contrast enhancement or cortical discontinuity suggests red marrow conversion or myelofibrosis. Falsely normal marrow on T1 can be seen with diffuse multiple myeloma or leukemic infiltration when the water to fat ratio is not sufficiently altered, as may be seen with lower grade tumors or earlier in the disease process.[22]

Bone marrow examination is the pathologic analysis of samples of bone marrow obtained via biopsy and bone marrow aspiration. Bone marrow examination is used in the diagnosis of a number of conditions, including leukemia, multiple myeloma, anemia, and pancytopenia. The bone marrow produces the cellular elements of the blood, including platelets, red blood cells and white blood cells. While much information can be gleaned by testing the blood itself (drawn from a vein by phlebotomy), it is sometimes necessary to examine the source of the blood cells in the bone marrow to obtain more information on hematopoiesis; this is the role of bone marrow aspiration and biopsy.

The ratio between myeloid series and erythroid cells is relevant to bone marrow function, and also to diseases of the bone marrow and peripheral blood, such as leukemia and anemia. The normal myeloid-to-erythroid ratio is around 3:1; this ratio may increase in myelogenous leukemias, decrease in polycythemias, and reverse in cases of thalassemia.[23]

In a bone marrow transplant, hematopoietic stem cells are removed from a person and infused into another person (allogenic) or into the same person at a later time (autologous). If the donor and recipient are compatible, these infused cells will then travel to the bone marrow and initiate blood cell production. Transplantation from one person to another is conducted for the treatment of severe bone marrow diseases, such as congenital defects, autoimmune diseases or malignancies. The patient's own marrow is first killed off with drugs or radiation, and then the new stem cells are introduced. Before radiation therapy or chemotherapy in cases of cancer, some of the patient's hematopoietic stem cells are sometimes harvested and later infused back when the therapy is finished to restore the immune system.[24]

Bone marrow stem cells can be induced to become neural cells to treat neurological illnesses,[7] and can also potentially be used for the treatment of other illnesses, such as inflammatory bowel disease.[8] In 2013, following a clinical trial, scientists proposed that bone marrow transplantation could be used to treat HIV in conjunction with antiretroviral drugs;[25][26] however, it was later found that HIV remained in the bodies of the test subjects.[27]

The stem cells are typically harvested directly from the red marrow in the iliac crest, often under general anesthesia. The procedure is minimally invasive and does not require stitches afterwards. Depending on the donor's health and reaction to the procedure, the actual harvesting can be an outpatient procedure, or can require 12 days of recovery in the hospital.[28]

Another option is to administer certain drugs that stimulate the release of stem cells from the bone marrow into circulating blood.[29] An intravenous catheter is inserted into the donor's arm, and the stem cells are then filtered out of the blood. This procedure is similar to that used in blood or platelet donation. In adults, bone marrow may also be taken from the sternum, while the tibia is often used when taking samples from infants.[16] In newborns, stem cells may be retrieved from the umbilical cord.[30]

The earliest fossilised evidence of bone marrow was discovered in 2014 in Eusthenopteron, a lobe-finned fish which lived during the Devonian period approximately 370 million years ago.[31] Scientists from Uppsala University and the European Synchrotron Radiation Facility used X-ray synchrotron microtomography to study the fossilised interior of the skeleton's humerus, finding organised tubular structures akin to modern vertebrate bone marrow.[31] Eusthenopteron is closely related to the early tetrapods, which ultimately evolved into the land-dwelling mammals and lizards of the present day.[31]

View post:
Bone marrow - Wikipedia

In genetics, a mosaic, or mosaicism, involves the presence of two or more populations of cells with different genotypes in one individual who has developed from a single fertilized egg.[1][2] Mosaicism has been reported to be present in as high as 70% of cleavage stage embryos and 90% of blastocyst-stage embryos derived from in vitro fertilization.[3]

Genetic mosaicism can result from many different mechanisms including chromosome non-disjunction, anaphase lag, and endoreplication.[3] Anaphase lagging is the most common way by which mosaicism arises in the preimplantation embryo.[3] Mosaicism can also result from a mutation in one cell during development in which the mutation is passed on to only its daughter cells. Therefore, the mutation is only going to be present in a fraction of the adult cells.[2]

Genetic mosaics may often be confused with chimerism, in which two or more genotypes arise in one individual similarly to mosaicism. However, the two genotypes arise from the fusion of more than one fertilized zygote in the early stages of embryonic development, rather than from a mutation or chromosome loss.

Different types of mosaicism exist, such as gonadal mosaicism (restricted to the gametes) or somatic mosaicism.

Somatic mosaicism occurs when the somatic cells of the body are of more than one genotype. In the more common mosaics, different genotypes arise from a single fertilized egg cell, due to mitotic errors at first or later cleavages.

In rare cases, intersex conditions can be caused by mosaicism where some cells in the body have XX and others XY chromosomes (46, XX/XY).[4][5] In the fruit fly Drosophila melanogaster, where a fly possessing two X chromosomes is a female and a fly possessing a single X chromosome is a sterile male, a loss of an X chromosome early in embryonic development can result in sexual mosaics, or gynandropmorphs.[6][7] Likewise, a loss of the Y chromosome can result in XY/X mosaic males.[8]

The most common form of mosaicism found through prenatal diagnosis involves trisomies. Although most forms of trisomy are due to problems in meiosis and affect all cells of the organism, there are cases where the trisomy occurs in only a selection of the cells. This may be caused by a nondisjunction event in an early mitosis, resulting in a loss of a chromosome from some trisomic cells.[9] Generally this leads to a milder phenotype than in non-mosaic patients with the same disorder.

An example of this is one of the milder forms of Klinefelter syndrome, called 46/47 XY/XXY mosaic wherein some of the patient's cells contain XY chromosomes, and some contain XXY chromosomes. The 46/47 annotation indicates that the XY cells have the normal number of 46 total chromosomes, and the XXY cells have a total of 47 chromosomes.

Around 30% of Turner's syndrome cases demonstrate mosaicism, while complete monosomy (45, X) occurs in about 5060% of cases.

But mosaicism need not necessarily be deleterious. Revertant somatic mosaicism is a rare recombination event in which there is a spontaneous correction of a mutant, pathogenic allele.[10] In revertant mosaicism, the healthy tissue formed by mitotic recombination can outcompete the original, surrounding mutant cells in tissues like blood and epithelia that regenerate often.[10] In the skin disorder ichthyosis with confetti, normal skin spots appear early in life and increase in number and size over time.[10]

Other endogenous factors can also lead to mosaicism including mobile elements, DNA polymerase slippage, and unbalanced chromosomal segregation.[11] Exogenous factors include nicotine and UV radiation.[11] Somatic mosaics have been created in Drosophila using Xray treatment and the use of irradiation to induce somatic mutation has been a useful technique in the study of genetics.[12]

True mosaicism should not be mistaken for the phenomenon of Xinactivation, where all cells in an organism have the same genotype, but a different copy of the X chromosome is expressed in different cells. The latter is the case in normal (XX) female mammals, although it is not always visible from the phenotype (like it is in calico cats). However, all multicellular organisms are likely to be somatic mosaics to some extent.[13]

Somatic mutation leading to mosaicism is prevalent in the beginning and end stages of human life.[11] Somatic mosaics are common in embryogenesis due to retrotransposition of L1 and Alu transposable elements.[11] In early development, DNA from undifferentiated cell types may be more susceptible to mobile element invasion due to long, un-methylated regions in the genome.[11] Further, the accumulation of DNA copy errors and damage over a lifetime lead to greater occurrences of mosaic tissues in aging humans. As our longevity has increased dramatically over the last century, our genome may not have had time to adapt to cumulative effects of mutagenesis.[11] Thus, cancer research has shown that somatic mutations are increasingly present throughout a lifetime and are responsible for most leukemia, lymphomas, and solid tumors.[14]

One basic mechanism which can produce mosaic tissue is mitotic recombination or somatic crossover. It was first discovered by Curt Stern in Drosophila in 1936. The amount of tissue which is mosaic depends on where in the tree of cell division the exchange takes place. A phenotypic character called "Twin Spot" seen in Drosophila is a result of mitotic recombination. However, it also depends on the allelic status of the genes undergoing recombination. Twin spot occurs only if the heterozygous genes are linked in repulsion i.e. trans phase. The recombination needs to occur between the centromere the adjacent gene. This gives an appearance of yellow patches on the wild type background in Drosophila. another example of mitotic recombination is the Bloom's syndrome which happens due to the mutation in the blm gene. The resulting BLM protein is defective. the defect in RecQ an helicase facilitates the defective unwinding of DNA during replication and is thus associated with the occurrence of this disease.[15][16]

Germline or gonadal mosaicism is a special form of mosaicism, where some gametesi.e., sperm or oocytescarry a mutation, but the rest are normal.[17][18]

The cause is usually a mutation that occurred in an early stem cell that gave rise to all or part of the gametes.

This can cause only some offspring to be affected, even for a dominant disease.

Genetic mosaics can be extraordinarily useful in the study of biological systems, and can be created intentionally in many model organisms in a variety of ways. They often allow for the study of genes that are important for very early events in development, making it otherwise difficult to obtain adult organisms in which later effects would be apparent. Furthermore, they can be used to determine the tissue or cell type in which a given gene is required and to determine whether a gene is cell autonomous. That is, whether or not the gene acts solely within the cell of that genotype, or if it affects the entire organism of neighboring cells which do not themselves contain that genotype.

The earliest examples of this involved transplantation experiments (technically creating chimeras) where cells from a blastula stage embryo from one genetic background are aspirated out and injected into a blastula stage embryo of a different genetic background.

Genetic mosaics are a particularly powerful tool when used in the commonly studied fruit fly, where specially-selected strains frequently lose an X[7] or a Y[8] chromosome in one of the first embryonic cell divisions. These mosaics can then be used to analyze such things as courtship behavior,[7] female sexual attraction,[19] and the autonomy or non-autonomy of particular genes.

Genetic mosaics can also be created through mitotic recombination. Such mosaics were originally created by irradiating flies heterozygous for a particular allele with X-rays, inducing double-strand DNA breaks which, when repaired, could result in a cell homozygous for one of the two alleles. After further rounds of replication, this cell would result in a patch, or "clone" of cells mutant for the allele being studied.

More recently the use of a transgene incorporated into the Drosophila genome has made the system far more flexible. The flip recombinase (or FLP) is a gene from the commonly studied yeast Saccharomyces cerevisiae which recognizes "flip recombinase target" (FRT) sites, which are short sequences of DNA, and induces recombination between them. FRT sites have been inserted transgenically near the centromere of each chromosome arm of Drosophila melanogaster. The FLP gene can then be induced selectively, commonly using either the heat shock promoter or the GAL4/UAS system. The resulting clones can be identified either negatively or positively.

In negatively marked clones the fly is transheterozygous for a gene encoding a visible marker (commonly the green fluorescent protein or GFP) and an allele of a gene to be studied (both on chromosomes bearing FRT sites). After induction of FLP expression, cells that undergo recombination will have progeny that are homozygous for either the marker or the allele being studied. Therefore, the cells that do not carry the marker (which are dark) can be identified as carrying a mutation.

It is sometimes inconvenient to use negatively marked clones, especially when generating very small patches of cells, where it is more difficult to see a dark spot on a bright background than a bright spot on a dark background. It is possible to create positively marked clones using the so-called MARCM ("mosaic analysis with a repressible cell marker", pronounced [mark-em]) system, developed by Liqun Luo, a professor at Stanford University, and his post-doc Tzumin Lee who now leads a group at Janelia Farm Research Campus. This system builds on the GAL4/UAS system, which is used to express GFP in specific cells. However a globally expressed GAL80 gene is used to repress the action of GAL4, preventing the expression of GFP. Instead of using GFP to mark the wild-type chromosome as above, GAL80 serves this purpose, so that when it is removed by mitotic recombination, GAL4 is allowed to function, and GFP turns on. This results in the cells of interest being marked brightly in a dark background.[20]

In 1929, Alfred Sturtevant studied mosaicism in Drosophila.[6] A few years later, In the 1930s, Curt Stern demonstrated that genetic recombination, normal in meiosis, can also take place in mitosis.[21][22] When it does, it results in somatic (body) mosaics. These are organisms which contain two or more genetically distinct types of tissue.[23] The term "somatic mosaicism" was used by C.W. Cotterman in 1956 in his seminal paper on antigenic variation.[11]

See the article here:
Mosaic (genetics) - Wikipedia

There is a fascination among some patients with umbilical cord, amniotic fluid/membrane, and placenta membrane as a means of getting the best, or the most stem cells, in stem cell therapy treatment.

In the opinion of researchers cited in this article, that fascination and the supportive claims are unfounded. Further, the treatments mentioned and advertised in some doctors office as amniotic stem cell therapy is in fact not even stem cell therapy.

I am going to discuss amniotic stem cell therapy, which is in fact amniotic tissue treatment, placenta treatments and umbilical cord stem cell therapy in this article.

Marc Darrow MD, JD. Thank you for reading my article. You can ask me your questions about stem cell therapy using the contact form below.

The Interventional Orthopedics Foundation is a non-profit that provides CME-accredited courses that teach simple to advanced injection skills.

In a December 2015 press release, the Foundation issued a warning about faulty stem cell products after testing placental tissue-derived products. The warning: The products contained no live stem cells.

Here are the five key points published in that press release:

Every day here in Los Angeles, you can see advertisements for seminars and webinars for LIVE amniotic stem cell therapy. What do they base this on?

It is based on research saying one thing and amniotic stem cell therapy marketers saying another. Here is an example of one study:

On the release of a 2012 study examining the theory that Amniotic stem cells derived from donated amniotic fluid could be stored in banks, shipped to doctors and researchers, and used for various therapies, study author Dr. Pascale Guillot of the Department of Surgery and Cancer at Imperial College of London described amniotic stem cells this way:

Amniotic fluid stem cells are intermediate between embryonic stem cells and adult stem cells. They have some potential to develop into different cell types but they are not pluripotent.

Pluripotent cells can give rise to all of the cell types that make up the body. To make amniotic cells pluripotent they have to be genetically modified. Genetically modified stem cells are drugs and must be approved by the Food and Drug Administration (FDA).

Dr. Guillot and her research team in fact were trying to turn stem cells from amniotic fluid into pluripotent stem cells by way of culturing. The purpose was to get them to a point where they could replace embryonic stem cells for laboratory testing. That they succeeded lead some in the amniotic/stem cell therapy business to believe that donated amniotic stem cells, taken from a caesarian section delivery donor, could be persevered, freeze-dried, and then shipped out to doctors offices as stem cell therapy injections for osteoarthritis.

So as mentioned, this often cited 2012 study was not about joint degeneration but as Dr. Guillot pointed out . . . We are particularly interested in exploring their use in genetic diseases diagnosed early in life or other diseases such as cerebral palsy, and further replacing the need for embryonic stem cells. Of course embryonic stem cell research is fraught with ethical challenges and limited supply.

Dr Paolo De Coppi, from the UCL Institute of Child Health in London, who jointly led the study with Dr Guillot, said: This study confirms that amniotic fluid is a good source of stem cells. The advantages of generating pluripotent cells without any genetic manipulation make them more likely to be used for therapy.

Read again This study confirms that amniotic fluid is a good source of stem cells, BUT FOR research looking at genetic pediatric disorders and how these stem cells can be harvested and stored for future research for genetic engineering.

We are often asked if we can use stored cord blood in our treatments. Umbilical cord blood is different from bone marrow stems cells. Cord stem cells are hematopoietic stem cells (which can differentiate only into blood cells), and not pluripotent stem cells (such as stem cells from bone marrow, which can differentiate into any type of tissue).The research surrounding the use of Cord Blood centers around blood and immune diseases such as leukemia, certain cancers and anemia. Speculation that cord blood stem cells may help with brain trauma injuries, cognitive disorders, and autism is being tested in the medical research.

This is the gray line with Amniotic/Placenta stem cells.A company the markets amniotic stem cells as injections and as mail order service says this:Researchers have discovered that the amniotic fluid has an extremely high concentration of stem cells, even more than bone marrow in adults. When processed at an FDA regulated lab, the biologic material ends up containing significant regenerative properties, such as growth factors, hyaluronic acid and stem cell activators.

Now on the same website the treatment is called: Amniotic derived stem cell activator injections

There is no argument that amniotic fluid contains stem cells, perhaps more so than bone marrow derived stem cells, BUT, from placenta to your joint pain the stem cells get lost along the way.

By name they are something that activates stem cells. But how? According to the makers of oral supplements sold as stem cell activators, they are protein building blocks that rejuvenate aging stem cells by way of DNA telemore support. The claim is you may live longer.

In stem cell therapy, stem cell activators are the building block or the scaffold which the stem cells begin its repair.

We are going to examine a 2013 study produced by MiMedx Group, Inc., a company that describes itself as the global premier processor, marketer, and distributor of human amniotic tissue.This study was also produced in conjunction with the Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine, the Georgia Institute of Technology. And the Angiogenesis Foundation. It was published in the International journal of wound healing.This is not a light-weight study.

Where are the stem cells in this study?

The researchers never say that the processed amniotic membrane have any. What they do say is that they stimulateHuman bone marrow mesenchymal stem cells already present in the body to multiple. (So does dextrose Prolotherapy and Platelet Rich Plasma).

Q. So what are stem cell activators?A. They are growth factors that help your own bone marrow mesenchymal stem cells multiply.

Q. So where are the amniotic stem cells?A. There are none

Researchers have discovered that the amniotic fluid has an extremely high concentration of stem cells, even more than bone marrow in adults. When processed at an FDA regulated lab, the biologic material ends up containing significant regenerative properties, such as growth factors, hyaluronic acid and stem cell activators. They do not survive the processing, only the remnants of their ability to activate bone marrow stem cells.

But isnt this still a great selling point for amniotic stem cell activator therapy?

No because there is already a well proven stem cell activator that works well and is a fraction of the cost, Platelet Rich Rich Plasma and dextrose prolotherapy.

Doctors from George Washington University and the University of Southern California went into this question with an open mind. Lets point out that we are NOT talking about stem cell therapy we are talking about placenta tissue preparation.

Here is what their study suggests:A review of the small number of reported studies revealed a high degree of variability in placental cell types, placental tissue preparation, routes of administration, and treatment regimens, which prohibits making any definitive conclusions. Currently, the clinical use of placenta is limited to only commercial placental tissue allografts, as there are no placenta-derived biological drugs approved for the treatment of orthopaedic sports medicine conditions in the United States.1

This April 2017 study is not very robust in its clinical recommendations.

So where did all this hype come from?

Doctors at Rush University School of Medicine wrote this in 2016 in the American journal of sports medicine:

Alter their biological properties?

With these type of research I would find it difficult to convince my patients, who are always eager for research to support their decision to undergo our treatments that the scientific community is as excited about amniotic/placenta stem cells as a potential help for their osteoarthritis.

1 McIntyre JA, Jones IA, Danilkovich A, Vangsness Jr CT. The Placenta: Applications in Orthopaedic Sports Medicine. The American Journal of Sports Medicine. 2017 Apr 1:0363546517697682.

2 Riboh JC, Saltzman BM, Yanke AB, Cole BJ. Human Amniotic MembraneDerived Products in Sports Medicine: Basic Science, Early Results, and Potential Clinical Applications. The American journal of sports medicine. 2016 Sep;44(9):2425-34.

Here is the original post:
Placenta | Amniotic tissue is not stem cell therapy - Dr ...

If you live in Blythewood or the surrounding area and need a trusted veterinarian to care for your pets look no further. Dr. Brian Gallery and Dr. Cara McKinnon are licensed SC veterinarian, treating small animals. Your pets health and well being are very important to us, and we take every possible measure to give your animals the care they deserve.

Dr. Gallery is a native of Columbia. He graduated from Heathwood Hall Episcopal High School,Lewis and Clark College, and The University of Georgia College ofVeterinary Medicine. Dr. Gallery enjoys meeting both first time andexperienced pet owners, and has a special interest in both canine andfeline medicine.

Dr. McKinnon is originally from Douglas, Ga. She graduatedfrom Coffee County High School, Valdosta State University, and TheUniversity of Georgia College of Veterinary Medicine. Dr. McKinnon enjoysall surgical cases and is especially interested in dental surgery, lasersurgery and soft tissue surgery.

Companion Animal Hospital is a fullservice veterinary hospital offering vaccines and annual check ups as wellas emergency and surgical care. We always gladly accept new clients, andlove to talk to new owners about their pets! In addition to veterinaryservices Companion Animal Hospital also offers daily grooming, bathing, andboarding in a fully climate controlled kennel with multiple oversized runs.

At Companion Animal Hospital, we treat your pets like the valued family members they are.

Dr. Brian Gallery and Dr. Cara McKinnonBlythewood Veterinarian | Companion Animal Hospital | (803) 786-2412

120 Blythewood Rd.Blythewood, SC 29016

Read the original:
Companion Animal Hospital - Veterinarian in Blythewood, SC

Our specialists are available on an appointment basis Monday through Friday to see pets as a referral from your primary veterinarian. We have an excellent team of specialists who are board-certified in Orthopedic Surgery, Soft Tissue Surgery, and Neurology!

While our doors may not be open 24/7, our hospital is always staffed with veterinary personnel capable of handling any emergency situation, as well as specialists who are available on call after hours for the most critical of patients.

VCA Animal Specialty Center of South Carolina serves the local community of Columbia, South Carolina, as well as reaching out across the state, and even into the state of Georgia. Although many of our doctors have been practicing much longer, VCA has been serving this area for over five years!

Everyone on our staff believes that the better we get to know your pets, the better we can provide the best possible care for them. In fact, when you come in, you'll see exactly why our veterinarians are praised for their kind and thorough care. We'll give you and your pet all the time you need, and never rush through a consultation.

More here:
Vets in Blythewood, SC - Local Vets and Veterinary Clinics ...

If you live longer than the average person, then you could be said to havelongevity. Striving for your maximum potential age is thegoal oflongevity. This potentially can be reached by practicing healthy behaviors and attitudes.

Longevity is defined as "long life" or "a great duration of life." The term comes from the Latin word longaevits. In this word, you can see how the words longus (long) and aevum (age) combine into a concept that means an individual who lives a long time.

The most important part of this definition is the comparative nature of it. Long life implies longer than somethingand that something is the average lifespan.

Biologists sometimes define longevity as the average lifespan expected under ideal conditions. It's hard to say what's ideal. Plenty of medical research is ongoing about the "right" amount and type of exercise to get, the best diet to eat to maximize longevity, and whether certain pharmaceuticals or supplements can help improve your longevity.

Lifespans have increased pretty dramatically over the last century or so, in large part due to advances in medicine that have nearly eliminated certain deadly infectious diseases.

The average baby born in 1900 lived about a half-century. Nowadays, the life expectancy of people in the United States is nearly 79 years on average81 years for women and 76 years for men, and in some countries, life expectancy is even longer.

It's very possible that humanity's true longevity might be much higher. Humans might live longer if they can create the ideal conditions of a healthy diet and exercise.

You may think that your genes determine your longevity, but the truth is genetics account for a maximum of 30 percent of your life expectancy. The rest comes from your behaviors, attitudes, environment, and a little bit of luck.

You may have heard about various life extension techniques. Keep in mind that none of them have been proven in humans and most are just theories. The only proven way to live longer is to live a healthy life.

If you want to beat the average and maximize your longevity, what should you do? Here's a list of things to consider:

Make a commitment today to make one healthy change a week. Before you know youll be feeling better and on the road to longevity.

See the rest here:
How You Can Increase Your Longevity

Let us continue our funding efforts for our future health. Our regular donations will help to speed up Scientific Research to prevent and reverse age-related diseases. You can consider following research groups suggested by members or any other research group working on longevity.

SENS Research Foundation: They fund research that uses regenerative medicine to repair the damage underlying the diseases of aging (about SENS)

LEAF/lifespan.io Various Campaigns such as Become a Lifespan Hero, NAD+ Mouse Project, MouseAge Project

Other options: LEAF on Amazon Smile, eBay, Humble Bundle

Crowdfunding project for the translation of the book Ending Aging (by Aubrey de Grey) into Portuguese.See Donation link and leafscience.org Article

Dog Aging Project: "The University of Washingtons Dog Aging Project is dedicated to promoting healthy aging in people and their companion animals."

National Institute on Aging (NIA) : "NIA, one of the 27 Institutes and Centers of NIH, leads the federal government in conducting and supporting research on aging and the health and well-being of older people". (mission)

The Longevity Research Institute. "They are designing and launching mouse studies for interventions.." read more on this Reddit Comment

.

Thanks to following members of this subreddit who have shared their donation efforts. These are based on their public comments on this subreddit. Please share your donation efforts here. It will motivate others to participate.

.

.

.

See more here:
Live forever or die trying. r/longevity - reddit

In 2017, for the first time, The Economist brought together Asian business leaders, political decision-makers and health-care entrepreneurs to discuss how to make longevity a source of healthy innovation. At the Longevity Summit 2018, The Economist will build on this momentum to foster thinking on the topic of living to 100.

The event will answer the following key questions:

About the 2018 summit:

The worlds over-60 population is already nearing a billionand its still growing. Low fertility rates and increasing life expectancy have the United Nations predicting that by 2050 there will be 2.1 billion of these older people, and around half of them will live in Asia.

Longevity is a polarising issue. Optimists enthuse about advances in biotechnology and the market power of a silver economy; doomsayers fear skyrocketing health-care costs and inadequate workforces. A more plausible, middle position is to see the challenges associated with an ageing population as inextricably linked with their solutions. Governments and businesses need healthy populations to sustain demand, productivity and growth. And as people age, they want to stay healthy, engaged and purposeful. Happily, these are complementary demands.

But across Asia, progress in meeting the challenges of ageing has been patchy. Japan and Singapore have made great strides in helping their populations cope with longevity. Hong Kong, Taiwan and Korea are catching up by embracing new ideas and policy solutions. Philippines, Vietnam and Malaysia enjoy demographic buoyancy, with younger populations for the moment, but in the coming decades they will face the same pressures as their greying neighbours. What lessons can Asias longevity leaders share when it comes to engaging the over-60 population in the economy and society? Can the longevity dividend offset the costs of increased demand for health care and social services?

Originally posted here:
The Longevity Summit 2018 | The Economist Events

POSTED ON 5/2/2014 IN Healthy Lifestyles BY Christopher Centeno

Fat stem cell therapy continues to explode, with literally 20 new clinics popping up every week. I blogged awhile back that fat stem cells taken from overweight patients are not as potent as fat taken from thinner patients. Three new studies published this past few months add to that discussion. The focus of the recent investigations are how disease, aging, and weight impacts fat stem cells. The first study looked at fat stem cells from patients with cardiovascular disease. First the good news, when fat stem cells from older patients with heart disease were compared to those from older patients without heart disease, there wasn't a difference in the ability of the fat stem cells to make new blood vessels. Now the bad news, fat stem cells from older patients in both categories were less able to make new blood vessels when compared to fat stem cells from younger patients. The second study also looked at fat stem cells and aging. The "money shot" graph from that paper is above. Regrettably this study wasn't very sophisticated and made little effort to look at stem cell quality like the first. They also only looked at the nucleated cell count in the fat, which is a very rough metric of the stem cells in the fat (only a very small portion of the nucleated cells are stem cells). For more information on what these numbers mean, see my Doctor-Patient Guide to what stem cell numbers mean. What did they find? This rough metric of a fat stem cell count declined substantially after age 40. After that age, it dropped to a bit more than half of the value that they found in women under 40. Finally, a third interesting study looked at the lifespan of fat stem cells from normal weight, obese, and post bariatric surgery patients. Interestingly, the stem cells from obese patients had a shorter lifespan and were less healthy than either the stem cells from the normal weight or post weight loss surgery patients. Basically, being overweight hurt the DNA of the fat stem cells. The upshot? Fat stem cells are impacted by aging and being overweight. Being older and heavy is likely a double whammy for your cells. While some of these issues can be dealt with via dosing (administer more fat stem cells), the third study showed that cellular DNA damage was accumulating in the fat stem cells of patients who were overweight. Therefore solving the issue in some patients may not be as easy as just increasing the dose.

The rest is here:
Fat Stem Cell Therapy: The Impact of Aging, Disease, and ...

NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used.

Sources Used in Current Review

Khardori, R. (Updated 2014 September 15). Type 1 Diabetes Mellitus. Medscape Drugs & Diseases [On-line information]. Available online at http://emedicine.medscape.com/article/117739-overview through http://emedicine.medscape.com. Accessed September 2014.

Khardori, R. (Updated 2014 September 16). Type 2 Diabetes Mellitus. Medscape Drugs & Diseases [On-line information]. Available online at http://emedicine.medscape.com/article/117853-overview through http://emedicine.medscape.com. Accessed September 2014.

Patel, S. and Reddy, D. (Updated 2012 September 18). Gestational Diabetes Testing Protocol. Medscape Drugs & Diseases [On-line information]. Available online at http://emedicine.medscape.com/article/2049380-overview through http://emedicine.medscape.com. Accessed September 2014.

Nichols, G. (2014 September 24). The Existential Question of Prediabetes. Medscape Multispecialty [On-line information]. Available online at http://www.medscape.com/viewarticle/831930 through http://www.medscape.com. Accessed September 2014.

Drobnik, J. and Schwartz, R. (Updated 2013 July 25). Dermatologic Manifestations of Hemochromatosis. Medscape Drugs & Diseases [On-line information]. Available online at http://emedicine.medscape.com/article/1104743-overview through http://emedicine.medscape.com. Accessed September 2014.

(2012 July). Prediabetes, What You Need to Know. National Diabetes Information Clearinghouse [On-line information]. Available online at http://diabetes.niddk.nih.gov/dm/pubs/prediabetes_ES/ through http://diabetes.niddk.nih.gov. Accessed September 2014.

(Updated 2014 February 12). Your Guide to Diabetes: Type 1 and Type 2. National Diabetes Information Clearinghouse [On-line information]. Available online at http://diabetes.niddk.nih.gov/dm/pubs/type1and2/index.aspx through http://diabetes.niddk.nih.gov. Accessed September 2014.

(2014 June). Causes of Diabetes. National Diabetes Information Clearinghouse [On-line information]. Available online at http://diabetes.niddk.nih.gov/dm/pubs/causes/Causes_of_Diabetes_508.pdf through http://diabetes.niddk.nih.gov. Accessed September 2014.

(Updated 2014 July 28). National Diabetes Statistics Report, 2014. Centers for Disease Control and Prevention [On-line information]. Available online at http://www.cdc.gov/diabetes/pubs/statsreport14.htm through http://www.cdc.gov. Accessed September 2014.

(Updated 2014 September 10). Diagnosis of Diabetes and Prediabetes. National Diabetes Information Clearinghouse [On-line information]. Available online at http://diabetes.niddk.nih.gov/dm/pubs/diagnosis/ through http://diabetes.niddk.nih.gov. Accessed September 2014.

(Updated 2014 August 27). Monogenic Forms of Diabetes: Neonatal Diabetes Mellitus and Maturity-onset Diabetes of the Young. National Diabetes Information Clearinghouse [On-line information]. Available online at http://diabetes.niddk.nih.gov/dm/pubs/mody/index.aspx through http://diabetes.niddk.nih.gov. Accessed September 2014.

Parkin, C. (2013 February). LADA, the Other Diabetes, Can Be Hard to Spot. Diabetes Forecast [On-line information]. Available online at http://www.diabetesforecast.org/2013/feb/lada-the-other-diabetes-can-be-hard-to-spot.html through http://www.diabetesforecast.org. Accessed September 2014.

(2013 September). Gestational Diabetes: What You Need to Know. National Diabetes Information Clearinghouse [On-line information]. Available online at http://www.diabetes.niddk.nih.gov/dm/pubs/gestational_ES/ through http://www.diabetes.niddk.nih.gov. Accessed September 2014.

(2014 January). Standards of Medical Care in Diabetes 2014. Diabetes Care Volume 37, Supplement 1 [On-line information]. Available online at http://care.diabetesjournals.org/content/37/Supplement_1/S14.full.pdf+html through http://care.diabetesjournals.org. Accessed September 2014.

(2014 January). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care Volume 37, Supplement 1 [On-line information]. Available online at http://care.diabetesjournals.org/content/37/Supplement_1/S81.full.pdf+html through http://care.diabetesjournals.org. Accessed September 2014.

(2013 September). Gestational Diabetes. American College of Obstetricians and Gynecologists [On-line information]. Available online at http://www.acog.org/Patients/FAQs/Gestational-Diabetes through http://www.acog.org. Accessed September 2014.

Copeland, K. et. al. (2013 January 28). Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents. Pediatrics v 131 (2) [On-line information]. Available online at http://pediatrics.aappublications.org/content/131/2/364.full?sid=d1840c80-287b-43ca-ac9c-68b0b1d5dfa8 through http://pediatrics.aappublications.org. Accessed September 2014.

(Reviewed 2013 August 2). Hemochromatosis. American Diabetes Association [On-line information]. Available online at http://www.diabetes.org/living-with-diabetes/complications/related-conditions/hemochromatosis.html through http://www.diabetes.org. Accessed September 2014.

Gebel, E. (2010 May). Another Kind of Diabetes: MODY, Often misdiagnosed, the disease is caused by a faulty gene. Diabetes Forecast [On-line information]. Available online at http://www.diabetesforecast.org/2010/may/another-kind-of-diabetes-mody.html through http://www.diabetesforecast.org. Accessed September 2014.

Gebel, E. (2010 May). The Other Diabetes: LADA, or Type 1.5, Latent autoimmune diabetes in adults is gradually being understood. Diabetes Forecast [On-line information]. Available online at http://www.diabetesforecast.org/2010/may/the-other-diabetes-lada-or-type-1-5.html through http://www.diabetesforecast.org. Accessed September 2014.

(2014 July). Overview of Diabetes in Children and Adolescents. From the National Diabetes Education Program [On-line information]. Available online at http://ndep.nih.gov/media/Overview-of-Diabetes-Children-508_2014.pdf through http://ndep.nih.gov. Accessed September 2014.

(October 2014) U.S. Preventive Services Task Force. Draft Recommendation Statement. Abnormal Glucose and Type 2 Diabetes Mellitus in Adults: Screening. Available online at http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementDraft/screening-for-abnormal-glucose-and-type-2-diabetes-mellitus through http://www.uspreventiveservicestaskforce.org. Accessed November 22, 2014.

July 25, 2013. Lisa Nainggolan. ACOG Issues New Practice Bulletin on Gestational Diabetes. Medscape News. Available online at http://www.medscape.com/viewarticle/808409 through http://www.medscape.com. Accessed October 29.

July 01, 2014. Brown, HL. ACOG Guidelines at a Glance: Gestational Diabetes. Available online at http://contemporaryobgyn.modernmedicine.com/contemporary-obgyn/content/tags/acog-guidelines/acog-guidelines-glance-gestational-diabetes-mellitus through http://contemporaryobgyn.modernmedicine.com. Accessed October 2014.

Soures Used in Previous Reviews

Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.

(1995-2004). Diabetes Mellitus. The Merck Manual of Medical Information-Second Home Edition [On-line information]. Available online at http://www.merck.com/mmhe/sec13/ch165/ch165a.html?qt=Diabetes&alt=sh through http://www.merck.com.

(2005 January). Diagnosis of Diabetes. National Diabetes Information Clearinghouse, NIH Publication No. 05-4642 [On-line information]. Available online at http://diabetes.niddk.nih.gov/dm/pubs/diagnosis/index.htm through http://diabetes.niddk.nih.gov. Reaccessed 2/20/08.

All About Diabetes. American Diabetes Association [On-line information]. Available online at http://www.diabetes.org/about-diabetes.jsp through http://www.diabetes.org. Reaccessed 2/20/08.

National Diabetes Fact Sheet. Centers for Disease Control [On-line information]. Available online at http://www.cdc.gov/diabetes/pubs/factsheet.htm through http://www.cdc.gov.

Jonnalagadda, S. (2004 February 19). Serum ketones. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003498.htm.

Magee, C. (2005 December 9, Updated). Ketones urine. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/003585.htm.

(2003). Ketone testing. National Academy of Clinical Biochemistry, Laboratory Medicine Practice Guidelines [On-line information]. PDF available for download at http://www.nacb.org/lmpg/diabetes/5_diabetes_keytone.pdf#search='%2C%20ketone%20diabetes' through http://www.nacb.org.

National Diabetes Information Clearinghouse: National Diabetes Statistics (2005). Available online at http://diabetes.niddk.nih.gov/dm/pubs/statistics/ through http://diabetes.niddk.nih.gov.

U.S. Preventive Services Task Force. Recommendations and Rationale: Screening for Gestational Diabetes Mellitus (February 2003). Available online at http://www.ahrq.gov/clinic/3rduspstf/gdm/gdmrr.htm through http://www.ahrq.gov.

American Diabetes Association. Executive summary: standards of medical care in diabetes2010. Jan 2010. Diabetes Care 33: S4-S10.

(January 2010) The Endocrine Society Statement on the use of A1c for Diabetes Diagnosis and Risk Estimation. PDF available for download at http://www.endo-society.org/advocacy/upload/TES-Statement-on-A1C-Use.pdf through http://www.endo-society.org. Accessed January 2010.

(Updated 2011 May 5). Basics about Diabetes. Centers for Disease Control and Prevention [On-line information]. Available online at http://www.cdc.gov/diabetes/consumer/learn.htm through http://www.cdc.gov. Accessed May 2011.

(2011). National Diabetes Fact Sheet, 2011. CDC [On-line information]. PDF available for download at http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf through http://www.cdc.gov. Accessed May 2011.

(Updated 2010 October). Type 2 Diabetes Fact Sheet. National Institutes of Health [On-line information]. Available online at http://report.nih.gov/NIHfactsheets/Pdfs/Type2Diabetes(NIDDK).pdf through http://report.nih.gov. Accessed May 2011.

Khardori, R. (Updated 2011 May 19). Type 2 Diabetes Mellitus. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/117853-overview through http://emedicine.medscape.com. Accessed May 2011.

Moore, T. (Updated 2011 April 13). Diabetes Mellitus and Pregnancy. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/127547-overview through http://emedicine.medscape.com. Accessed May 2011.

Mayo Clinic Staff (2011 March 9). Diabetes. MayoClinic.com [On-line information]. Available online at http://www.mayoclinic.com/health/diabetes/DS01121/METHOD=print through http://www.mayoclinic.com. Accessed May 2011.

Grenache, D. (Updated 2011 April). Diabetes Mellitus. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/DiabetesMellitus.html#tabs=0 through http://www.arupconsult.com. Accessed May 2011.

Kerr, M. (Updated 2009 June 23) ADA 2009: New Blood Test Bridges Time Gap Between Serum Glucose and Hemoglobin A1c. Medscape Medical News [On-line information]. Available online at http://www.medscape.com/viewarticle/704358 through http://www.medscape.com. Accessed May 2011.

American Diabetes Association. Standards of Medical Care in Diabetes2011. Diabetes Care January 2011 34:S11-S61. Available online at http://care.diabetesjournals.org/content/34/Supplement_1/S11.full throughhttp://care.diabetesjournals.org.

Metzger BE, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33: 676-82.

Read this article:
Diabetes - Lab Tests Online